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Abbreviations 
 
Abs   antibodies 
Bag-1   Bcl-2 associated athanogene-1 
Bax   Bcl-2 associated X protein 
Bcl-2   B-cell lymphoma-2 
BgVV Bundesinstitut für gesundheitlichen Verbraucherschutz und 
Veterinärmedizin 
Caspases  cysteine-aspartic-acid-proteases CD cluster of differentiation 
cDNA   complementary deoxyribonucleic acid 
CHAPS  3,3–cholamidopropyldimethyl ammonio–1-propanesulfonate 
Cy5   carbocyanine 5 
DAB   diaminobenzidin 
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dNTP   deoxy-nucleosidtriphosphate 
e.g.   for example 
FACS   flow activating cell sorting  
FC   flow cytometry 
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h   hour 
HEPES  4,2–hydroxyethylpiperazine–1- ethanesulfonic acid 
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i.e.   that is 
IFN   interferon 
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NTC   no template control 
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RNAse  ribonuclease 
RSA   recurrent spontaneous abortion 
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RT–PCR  reverse transcriptase-polymerase chain reaction 
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1. Introduction 
 
In 1953, the Brazilian-born British biologist Sir Medawar first discussed the 
immunological problem of pregnancy, where the mother contrive to nourish within 
herself, a fetus that is an antigenically foreign body. Later, several theories were 
proposed in order to explain why the fetus is not rejected from its mother. The 
placental trophoblast cells have been defined as a barrier between mother and 
fetus (Chaouat et al., 1983; Wegmann et al., 1988), therefore immunological 
rejection cannot be induced since there is a lack of paternal major 
histocompatibility complex (MHC) alloantigen (class I and II) expression (Hunt et 
al., 1988). Studies disproved these theories. Mother and fetus interact dynamically 
with each other: maternal lymphocytes pass into the fetus and vice versa 
(Piotrowsky and Croy, 1996; Bonney and Matzinger, 1997), and murine 
trophoblastic cells express fetal class I MHC molecules (Chatterjee-Hasrouni and 
Lala 1981; Zuckerman and Head 1986). Moreover, Clark and colleagues (1991) 
demonstrated that the fetus is rejected as an allograft if removed from its place 
and transplanted in muscle or kidney of the mother, thus underlying the ability of 
the fetus to express paternal MHC antigens. Other studies proposed that 
trophoblast cells are able to induce apoptosis of maternal Th1 type lymphocyte by 
releasing FAS ligand (FASL) at the feto-maternal interface (Zhang et al., 1989; 
Runic et al., 1996; Hunt et al., 1997; Kauma et al., 1999), in order to protect the 
fetus from rejection. However, an lpr mutation - defective in the Fas function - had 
no effect on pregnancy outcome in mice, whereas with gld mutation – lacking 
functional FasL – the mice displayed extensive leukocyte infiltrates and cell death 
at the feto-maternal interface, delivering small litters (Hunt et al., 1997). Recently, 
two novel mechanisms involved in pregnancy protection were introduced in th 
reproductive field: heme oxygenase (HO) enzymes system and regulatory T cells 
(Treg). HO enzyme is responsible for the heme degradation into bilirubin and CO. 
Studies proposed HO allowing the acceptance of mouse allograft (Soares et al., 
1998; Woo et al., 1998; Araujo et al., 2003). Recently, diminished expression of 
both HO isoforms (HO-1 and HO-2) at the feto-maternal interface of mice 
undergoing Th1-mediated abortion compared to normal pregnant mice have been 
reported, suggesting a protective effect of these enzymes in allogenic murine 
pregnancy maintenance (Zenclussen et al., 2002b, 2005a). Moreover, in humans, 
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a significant reduction of both HO-1 and HO-2 expression has been also revealed 
in placenta samples from patients with pregnancy complications compared to 
normal pregnant women (Barber et al., 2001; Zenclussen et al., 2003b). On the 
other hand, Treg CD4+CD25+ cells, a unique subpopulation of T cells, induce a 
local immune privilege, allowing graft acceptance (Waldmann et al., 2006). During 
pregnancy, a diminished number of Treg cells have been observed in mice 
undergoing abortion compared to normal pregnancy (Zenclussen et al., 2005b; 
2006), and, moreover, during human gestation elevated levels of circulating Tregs 
were associated with successful pregnancy (Somerset et al., 2004).  
A burning point in pregnancy-related research is represented by the role of pro- 
(Th1 such as TNF-α or IFN-γ) and anti-inflammatory cytokines (Th2/Th3, such as 
IL-10, TGF-β) in determining successful pregnancy or abortion. Studies indicated 
that the Th1/Th2 cytokine ratio might not be the overall explanation for successful 
reproductive outcome, but a simplification (Svensson et al., 2001; Zenclussen et 
al., 2002a; Chaouat et al., 2003). In mice, production of type 1 cytokines at 
implantation sites has been found essential for normal implantation, whereas in 
human normal pregnancy is associated with a systemic inflammatory response. In 
general, it is accepted that local changes in the balance of Th1/Th2 cytokine 
profiles occurring during pregnancy within the maternal uterus and at the feto-
maternal interface contributes to implantation, placental development and fetal 
survival. Augmented Th1 cytokines production is involved in immunological 
rejection of the fetus, and, particularly TNF-α, triggers apoptosis (Sidoti-de-Fraisse 
et al., 1998; Baud and Katrin, 2001).  
 
This work is aimed to investigate the incidence of apoptosis in a well-known 
experimental model of Th1-induced abortion, characterized by increased local 
TNF-α levels. Moreover, considering the protective effect of heme oxygenase 
(HO) proposed during allogeneic pregnancy, we studied whether this effect is due 
to the anti-apoptotic properties of HO since the mechanisms involved in its 
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1.1. Abortion 
The common term abortion defines the premature termination of pregnancy and 
expulsion from the human maternal uterus of an embryo or a fetus weighing 500 g 
or less, incapable of survival (Stirrat, 1990). The weight criterion, associated with 
20-22 weeks of gestation, is considered as the minimum for viability and to 
discriminate between pathological causes (Stirrat, 1990). In humans, miscarriage 
very often occurs during the first trimester, prior to week 13th of pregnancy, 
whereas in mice at the 8th day of pregnancy (Suzuki et al., 1997). In mice the term 
abortion has been substituted with resorption, in order to describe sites identified 
by their small size and necrotic hemorrhagic appearance, compared to normal 
embryos and placentas, (Suzuki et al., 1997). 
 
1.2. Recurrent Spontaneous Abortion (RSA) 
Recurrent spontaneous abortion (RSA) is usually defined as the loss of three or 
more consecutive pregnancies (Stirrat, 1990; Crosignani et al., 1991, Coulam et 
al., 1996; Pandey et al., 2005). “Primary recurrent spontaneous aborters” are 
considered those who have lost all previous pregnancies and have no live birth, 
while “secondary recurrent spontaneous aborters” have at least one successful 
gestation irrespective of the numbers of pregnancy losses (Stirrat, 1990). 
Epidemiological studies suggest that the risk of subsequent pregnancy losses is 
approximately 24% after two clinical abortions, 30% after three and 40% after four 
consecutive spontaneous pregnancy losses (Stirrat, 1990; Regan, 1991). The 
reasons associated with repeated abortion are multifactorial and can be divided 
into embryological (mainly due to an abnormal karyotype, 3-6%; Coulam et al., 
1996) and maternal driven causes, like anatomical (e.g. uterus malformation, 1-
16%), endocrinological (5-20%), placental anomalies, infections (0.5%, Pandey et 
al., 2005), stress factors (Arck et al., 2001), autoimmune factors (20%, Pandey et 
al., 2005). Since women experiencing RSA represent a heterogeneous population, 
specific markers are necessary to identify those who will respond to various 
treatments. Diagnostic tests have been used to identify putative immunological 
causes associated with RSA including autoantibodies such as anti-phospholipid 
antibodies (APA), anti-nuclear antibodies (ANA) but not anti-thyroid antibodies 
(ATA, Coulam et al., 1997). Several treatments have also been adopted to 
improve pregnancy outcome in women with RSA such as aspirin/heparin therapy, 
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intravenous immunoglobulin (IV Ig) therapy, lymphocyte immunotherapy or 1α, 25-
dihydroxy-vitamin-D3 (VD3) therapy depending on the diagnosis (Pandey et al., 
2005). Unfortunately, in these treatments used for improving pregnancy outcome 
in women with RSA, several risks and side effects have been reported. 
 
1.3. The placenta 
1.3.1. General features 
Fetal growth and survival are critically dependent on the placenta, an organ 
resulting by the coexistence of two different components, the decidual tissue and 
the trophoblastic cells, which have maternal and fetal origin, respectively 
(Mossmann, 1937). The placental specific tissue is involved in regulating the 
physiologic contacts between mother and its fetus, providing the embryo with 
nourishment, eliminating its wastes and exchanging respiratory gases, in order to 
allow fetal optimal development. In addiction, the placenta directs maternal 
endocrine, immune, and metabolic functions to the embryo’s advantage 
(Handwerger and Freemark, 2000). Placenta could be defined as an endocrine 
organ since it is an important source of hormones, such as human chorionic 
gonadotrophin, produced by the trophoblast before implantation (Handwerger and 
Freemark, 2000) and human placental lactogen, a protein hormone similar to 
growth hormone, influencing the preparations of the breasts for lactation and the 
lipid or carbohydrate metabolism (Handwerger and Freemark, 2000).  
 
1.3.2. The human and murine placenta 
The development of human as well as murine placentas takes place in three 
phases: implantation, decidualization and placentation. Implantation is represented 
by a complex sequence of events, describing the process of blastocyst attachment 
to the maternal endometrium before its invasion into the tissue (Aplin et al., 1991; 
Abrahamsohn and Zorn, 1993). During early pregnancy, the uterus changes from 
an irregular shape to a lumen with crypts, where blastocysts become positioned 
before starting to implant. In humans, implantation takes place between days 6 
and 7 post coitum (Bernische and Kaufmann, 2001), whereas in mice between 
days 4 and 5 after vaginal plug detection (Reinius, 1967). The contact between the 
embryo and the surface of the uterine epithelium increases gradually at the 
beginning of implantation and this is probably caused by a combination of 
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blastocyst swelling and closure of the uterine lumen (Bernische and Kaufmann, 
2001). In order for implantation to be successful, the embryo must reach a proper 
stage of development and the endometrium must exhibit a state of receptiveness 
toward the embryo. After implantation, the maternal endometrium progressively 
transforms into decidua (decidualization process), and then placental formation 
starts until development is complete (placentation process, Bernische and 
Kaufmann, 2001).  
 
1.3.2.1. The human placental structure 
The human placenta is a discoid organ about 25 cm in diameter and 3 cm in 
thickness. Placenta is formed by the chorionic plate facing the fetus, where the 
umbilical cord is attached, and the basal plate which abuts the maternal 
endometrium (Fig.1; Bernische and Kaufmann, 2001). Internally human placenta 
consists of a vast array of finger-like processes, the villi. These arise from the 
chorionic plate as stem villi, and branch repeatedly to give rise to intermediate and 
finally terminal villi (Georgiades et al., 2002). Terminal villi are the most important 
sites for maternal-fetal exchange, bathing directly by maternal blood. The outer 
surface of the villus is formed by terminally differentiated, multinucleated 
syncytiotrophoblast cells and a stem cell population called cytotrophoblasts, which 
differentiate and fuse to the syncytiotrophoblasts (Georgiades et al., 2002). 
 
Fig. 1
 Structure of the human placenta. In A, a general view of fetus with its placenta is shown. 
The fetal blood vessels attach to the placenta through the umbilical cord. The mother's blood 
supply runs through the placenta, which supplies the fetus with nutrients and removes waste 
products from the fetal blood (1. umbilical cord; 2. amniotic fluid; 3. amniochorionic membrane, 
from www.mhhe.com). In B, human placenta with fetal villi containing fetal vessels and the 
C B A 
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umbilical cord are depicted. The villi are bathed in maternal blood. In C, two fetal villous trees 
illustrate the complex branching pattern (from Rinkenberger and Werb, Nature Genetics 2000). 
 
 
The physiologically important exchange of substances between maternal and fetal 
blood takes place through the feto-maternal interface situated between the two 
circulations, where the following cell types are situated: a) the villous trophoblasts; 
b) a basement membrane closed to the syncytiotrophoblasts; c) a villous core; d) 
basement membrane; e) fetal capillary endothelial cells (Bernische and Kaufmann, 
2001). Moreover, decidual tissue, representing the maternal part, is characterized 
by polygonal- or round-shaped cells together with a highly vascularized area rich 
in extravillous cytotrophoblasts. Other cells involved in immune response are 
usually populating the decidua such as uterine natural killer cells (uNK) that 
represent the majority of leukocytes infiltrated at the time of implantation (Aplin et 
al., 1991; Bernische and Kaufmann, 2001), macrophages, T cells, B cells, 
granulocytes, plasma cells (Bernische and Kaufmann, 2001). 
 
1.3.2.2. The murine placental structure 
The murine placenta develops until the 14th day of gestation, whereas the fetus 
continues growing until delivery. This feature could be associated with the 
observation that ten or more fetuses may coexist in the uterus. Suzuki and 
colleagues (1997) nicely reported as murine placental growth is correlated to the 
formation of a more complex labyrinth rather than to any increase in size after 
twelve days of pregnancy (Fig. 2).  
 
Fig. 2 Comparison of size 
development between murine 
placentas (bottom) and fetuses 
(top) from fetal day 12 to just after 







13 14 18 17 16 15 New born 
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The murine placenta be could divided into four areas such as 1) the chorionic 
plate; 2) the labyrinthic zone; 3) the junctional zone formed by spongiotrophoblast 
cells and giant cells; 4) the decidua basalis, whose function is the nourishment of 
the embryo, the contribution of formation of individual embryonic vascular systems 
during placental development, and restriction of trophoblast invasion 
(Abrahamsohn and Zorn, 1993). In the murine placenta, four differentiated 
trophoblast cell phenotypes can be readily defined (Georgiades et al., 2002), such 
as a) The trophoblast giant cells, morphologically characterized by a big nucleus 
continuously producing DNA without cell division though a process called 
endoreduplication, and eosinophilic material in the cytoplasm. These cells exhibit 
invasive characteristics and posses significant endocrine activities. They are in 
contact with the maternal part, represented by round or polygonal decidual cells. 
b) The spongiotrophoblast cells, morphologically distinct from giant cells but with 
the same endocrine properties. c) The trophoblasts rich in glycogen, called 
glycogen cells. d) The labyrinthic cells forming a region containing fetal and 
maternal blood channels that circulate independently, and allowing physiological 
exchanges such as nutrients and oxygen to the fetus or waste products to the 
mother. Murine placenta and its internal organization are illustrated in Figs. 3 A 














Fig. 3 In A, general view of mouse fetus and its placenta in contact with the maternal part 
(deciduas; from Rinkenberger and Werb, Nature Genetics 2000). In B, the mature murine placenta 
with its cellular populations, decidual cells, giant cells, spongiotrophoblast cells, glycogen cells and 
labyrinthic cells (from Watson and Cross, Physiology 2005). 
A B 
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1.4. Mice and reproduction 
Female mice have an estrous cycle (periodic state of sexual excitement, that 
immediately precedes ovulation and during which the female is most receptive to 
mating) which is 4-6 days long (Lee Silver, 2001). Following copulation, female 
mice will normally develop a vaginal plug, which prevents further copulation. This 
plug (ejaculate from the male) stays in place for about 24 hours. The gestation 
period is about 19-21 days. The litter size is between 3 and 14 (average 6-8). The 
newborn are blind and furless. Fur starts to grow some three days after birth and 
the young open their eyes one to two weeks after birth. Females reach sexual 
maturity at about 6 weeks, whereas males after 8 weeks, but both can breed as 
early as 35 days (Lee Silver, 2001). 
 
1.4.1. The murine combination CBA x DBA/2: a model to study spontaneous 
abortion 
The mouse is extensively used as a model system to understand the genetic 
control of human development and several diseases. Beyond the readily available 
mouse mutations, this animal continues to represent the mammal of choice in 
research for a lot of compelling reasons such as low cost, a very short generation 
time and their docile and easy handling. Moreover, they are small enough (15-19 
cm including the tail) so that thousands can be housed in relatively small rooms 
and they breed readily in captivity. Mice are mainly used as a model for human 
diseases in order to develop new drugs, and to test the safety of proposed drugs.  
In pregnancy-related research, Clark and colleagues (1980) first discovered an 
increased rate of resorption (about 20-40%) when mating CBA/J (H-2k) female 
mice with DBA/2J (H-2d) males, which did not occur if mated with other H-2d 
bearing males like BALB/c. The abbreviation “H-2” refers to the mouse 
histocompatibility complex (MHC), which has a high degree of homology with the 
human leukocyte antigen (HLA) complex (the human MHC). The increased 
resorption rate, calculated as number of abortions in relation to the total number of 
implantations (Clark et al., 1980, Chaouat et al., 1986), occurs in certified strains 
of CBA/J female mice originating from Jackson Laboratory’s line (Bar Harbor, Main 
U.S.A.), therefore represented by a “J”. Over 20 generations of sister x brother 
inbreeding, all are genetically as alike as possible, being homozygous at more 
than 98% of their loci (Staats, 1985). Increased abortion or resorption rates 
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observed in CBA/J females previously mated with DBA/2J males have been 
associated with a high amount of Th1 cytokines at the feto-maternal interface 
(Raghupathy, 1997, 1999; Clark et al., 1999; Chaouat et al., 2003; Zenclussen et 
al., 2002a, 2003), therefore the combination CBA/J x DBA/2J is defined as an 
immunological abortion model for human pregnancy failure (Dealtry et al., 2000). 
The role of Th2-type cytokines in reducing fetal resorption was demonstrated by 
Chaouat and colleagues (1995), as they observed that placentas from resorption-
prone CBA/J x DBA/2J mating produced less IL-4 and IL-10 than the control 
combination, CBA/J x BALB/c. Moreover, injection of neutralizing anti-IL-10 
antibody in DBA/2J-mated CBA/J females increased the resorption rate, while anti-
IFN-γ antibody partially reduced the number of rejected feti (Chaouat et al., 1995). 
Thus, successful pregnancy was thought to be a Th2 phenomenon (Wegmann et 
al., 1993; Chaouat et al., 1995, 2003; Clark et al., 1999), resulting from both down-
regulation of Th1 type cytokine production, and the limitation of any resulting 
inflammatory responses. (Dealtry et al., 2000). 
 
1.5. Reproductive Immunology 
1.5.1. Hypothesis on mechanisms involved in fetal rejection 
Why does the fetus survive within the maternal uterus despite its paternal 
inheritance? Unfortunately, nowadays, this represents an unanswered question. 
Several studies have concentrated on the mechanisms allowing the fetus to 
survive without being rejected. Initially, in the 1953 Sir Medawar first recognized 
the paradoxical nature of the immunological relationship between the pregnant 
mother and her antigenically foreign child (a work which earned him a Nobel 
prize). He proposed several reasons why the fetus does not habitually provoke an 
immunological reaction from its mother, namely (1) the existence of an anatomical 
separation of the embryo from its mother, a barrier considered at that time 
impermeable to the maternal cells; (2) the antigenic immaturity of the fetus 
associated with the (3) immunological inertness of its mother. Years later, Chaouat 
and colleagues (1983) and Wegmann (1988) revisited the concept of the 
anatomical separation and proposed the “trophoblast barrier-immunotrophism 
mechanism”, where the trophoblast cells play a protective role for the rejectable 
fetus within the maternal immune system. Later, several studies described as 
maternal lymphocytes pass into the fetus and vice versa, pointing to a cellular 
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interaction between mother and fetus (Piotrowsky and Croy, 1996; Bonney and 
Matzinger, 1997). Another hypothesis proposed was the lack of expression of 
paternal major histocompatibility complex (MHC) alloantigens (classes I and II) on 
the fetal trophoblast (cells having paternal origin) forming the feto-maternal 
interface, considered a possible protection from maternal immune rejection (Hunt 
et al., 1988), although previously studies agreed that some murine trophoblast 
cells express fetal class I MHC molecules (Chatterjee-Hasrouni and Lala 1981; 
Zuckerman and Head 1986). Moreover, Clark and colleagues (1991) 
demonstrated that the fetus is rejected as an allograft if removed from its place 
and transplanted in muscle or kidney of the mother, thus underlying the ability of 
the fetus to express paternal MHC antigens.  
The fetus has also been defined as a parasite taking all nutrients required from its 
mother and giving her back the wastes, and the placental trophoblast cells have 
been resembled to a successful tumor protecting the fetus and growing 
undisturbed within the maternal uterus until it reaches the vessels (Clark et al., 
1999). From the end of the ´80s other concepts were suggested in the 
reproductive immunology field, such as the ability of the trophoblast to induce 
apoptosis of maternal Th1 type lymphocyte by releasing FAS ligand (FASL) at the 
feto-maternal interface (Zhang et al., 1989; Runic et al., 1996; Hunt et al., 1997; 
Kauma et al., 1999). As matter of fact, the local production of FasL represented a 
mechanism through which trophoblast cells may induce tolerance and self-
regulate survival during invasion and subsequent placentation. However, lpr 
mutation in mice – resulting in loss of Fas function- had no effect on pregnancy 
outcome (Hunt et al., 1997). Recent studies proposed no evidence for apoptosis of 
decidual leukocytes in normal and abnormal pregnancy in humans (Pongcharoen 
et al., 2004), showing that trophoblast survival is not depending upon FasL-
mediated apoptosis of maternal leukocytes at the feto-maternal interface. 
Moreover, the specialized fetal tissue in contact with maternal uterus could 
contribute to tolerance by mechanisms such as inactivation of natural killer (NK) 
cells through HLA-G expression (Rouas-Freiss et al., 1997) or depleting 
tryptophan (Munn et al., 1998). A point of continued heated debate in pregnancy 
research is the involvement of pro- and anti-inflammatory cytokines in determining 
either successful pregnancy or abortion. In fact, it was proposed that pathologic 
pregnancies leading to abortion are characterized by cell-mediated (Th1) 
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immunity, and that successful pregnancies are biased towards a T helper type 2 
(Th2) response. This concept was often defined as the “Th1/Th2 paradigm in 
pregnancy”, now considered too simplistic because the production of Th1 
cytokines is essential for implantation and a correct placental development (Joswig 
et al., 2003). Novel studies suggested the existence of alternative pathways 
inducing tolerance during pregnancy. Cells expressing indolamine 2,3-
dioxygenase (IDO) were proposed to represent an immunosuppressive barrier 
protecting the fetus from maternal T cell immunity (Munn et al., 1998; Mellor and 
Munn, 2001), suggesting IDO as an alternative pathway leading to fetal tolerance. 
However, new data re-questioned the importance of IDO due to the normality of 
pregnancy outcome in mice IDO-/- (Baban et al., 2004). CD25+CD4+ regulatory T 
cells (Treg) became evident for their potential protective ability to suppress 
activation of the immune system, therefore in homeostasis and tolerance to self 
(Sakaguchi et al., 1995; 2004). Aluvihare and colleagues suggested an important 
role of Treg in a model of normal murine pregnancy (2004). Our group recently 
reported the essential role of Treg in pregnancy, which consists in protecting the 
fetus from attacks by maternal immune system (Zenclussen et al., 2005b, 2006). 
In fact, the transfer of Treg cells isolated from normal pregnant mouse and injected 
into DBA-mated CBA/J female mice completely prevented fetal rejection 
(Zenclussen et al., 2005b). These and other studies suggest that during normal 
pregnancy a systemic expansion of maternal CD25+ T cells is induced and is 
capable of suppressing alloresponses, whereas absence of regulatory T cells is 
associated to an aggressive response against the fetus by the maternal immune 
system, leading to abortion (Aluvihare et al., 2004; Zenclussen et al., 2005b, 
2006). An emerging mechanism involved in inducing fetal survival is represented 
by the heme oxygenase (HO) enzyme pathway. HO proteins play an important 
role in allowing graft acceptance (Soares et al., 1998); its up-regulation is further 
associated with successful pregnancy, whereas diminished levels of HO lead to 
abortion and acute graft rejection (Soares et al., 1998; Zenclussen et al., 2003b; 
2005a; Sollwedel et al., 2005; Zenclussen M.L. et al., 2006).  
Very recently, Mincheva-Nilsson and colleagues (2006) proposed that proteins A 
and B (MICA and MICB) appear to suppress immune activity by binding to the NK 
cell receptor (NKGG 2D). In this work, they found that human placentas express 
mRNA for MICA and MICB, and that MIC protein expression was found in the 
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outermost fetal component of the placenta – the syncytiotrophoblast cells -. They 
observed a reduced expression of NKG2D in white blood cells of pregnant women 
(approximately 55%) compared to non-pregnant ones , pointing to a possible novel 
immune escape mechanism for fetal survival.  
 
Despite years of research in reproductive immunology, the main mechanisms 
involved in fetal tolerance remain unclear, although new interesting pathways are 
emerging which might open novel therapeutic opportunities. 
 
1.5.2. Cytokines network at the feto-maternal interface 
1.5.2.1. Cytokines: general features 
Cytokines are peptides with a molecular weight < 100 kDa, with pleiotropic 
regulatory effects on haematopoietic and many other cells, which participate in 
host defense and repair processes (Vilcek, 1998). The term “cytokine” includes 
lymphocyte-derived factors such as “lymphokines” (Interleukins, IL, Interferons, 
IFN, Tumor necrosis factors, TNF), monocyte-derived factors called “monokines”, 
haematopoietic “colony stimulating factors”, “growth factors (GF)” of the 
connective tissue and chemoattractant cytokines (chemokines, CC; Vilcek, 1998). 
Cytokines are produced by cell-mediated as well as innate immunity. An important 
source of cytokines is represented by helper T lymphocytes (Th lymphocytes). 
Cytokines bind to high-affinity receptors on target cells (most act on the cells that 
produce them, so called autocrine action, or in adjacent cells, paracrine action) to 
promote cytokines gene transcriptions mainly through signal transducers and 
activation of transcription (Stat) pathways (Stat-3, -4 or -6 pathways are activated 
after binding of Th1 or Th2 cytokines) (Jacobson et al., 1995; Kaplan et al., 1996; 
O`Garra and Naoko, 2000).  
 
1.5.2.2. Cytokines: role during pregnancy 
During pregnancy, the cross talk among maternal and fetal tissues could 
contribute to the maintenance of gestation, and its disturbance (i.e. implantation 
failure, preeclampsia) might result in abortion. During gestation, cytokines are 
mainly involved in (1) the stimulation of the growth, differentiation and function of 
maternal epithelial cells from uterus and tubes; (2) stimulation of the growth, 
differentiation of the embryo before and after trophoblast implantation; (3) 
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coordination and synchronization during embryo development, and they are 
involved in the relationship at the feto-maternal interface (Tabibzadeh and 
Babaknia 1995; Dealtry et al., 2000). Placental tissue produces cytokines and 
hormones, which are essential in the regulation at the feto-maternal interface. 
Saito (2000) nicely depicted a hypothetical scenario showing cross talk between 
ovary, placenta and decidua necessary to ensure successful pregnancy. As 
illustrated in Figure 4, the ovary releases progesterone hormone resulting in 
stimulation of Th2 cells to produce cytokines. Th2 cytokines such as IL-4 and 
leukemia inhibitory factor (LIF) promote the secretion of human chorionic 
gonadotropin (hCG) from placental trophoblasts (Saito et al., 1997), which further 
induces progesterone production from the ovary, resulting again in Th2 cell 
induction. Moreover, Th2 cytokines such as IL-4 and IL-10 are known as factors 
able to induce differentiation of Th2 lymphocytes from Th0 cells (Mosmann and 
Sad, 1996), and may control intrauterine natural killer (NK) cells by inhibiting their 
augmentation through IL-2Rα IL-2Rβ, IL2Rγ control, therefore preventing possible 
attacks on the trophoblasts (Saito et al., 1996). Placental cells (trophoblasts, Tc) 
and decidual macrophages (MΦ), both of which have tryptophan catabolic 
enzymes (such as indolamine 2,3-dioxygenase, IDO) involved in controlling the 
activation of maternal cytotoxic T cell, collaborate in order to protect the placental 
tissue against attacks by maternal T cells (Munn et al., 1998). IDO expression at 
the feto-maternal interface was proposed to be necessary to prevent 
immunological rejection of fetal allograft as the inhibition of tryptophan catabolism 
during pregnancy allows maternal lymphocytes to mediate abortion (Munn et al., 
1998). Munn and colleagues (1998) hypothesized that T cells possess a specific 
cell-cycle regulatory checkpoint sensitive to the level of tryptophan, suggesting 
that IDO suppresses T cell activation and proliferation in local microenvironments 
by nutrient depletion. Since the exact mechanism by which IDO-expressing 
trophoblast cells protect the allogeneic fetus from its rejection remains to be 
elucidated and considering that recently studies (Baban et al., 2004) describe as 
mice IDO-/- have normal gestation, the importance of IDO in determining 


























1.5.2.3. The multifunctional cytokine TNF-α during pregnancy 
TNF-alpha is a pleiotropic pro-inflammatory cytokine with a wide variety of 
functions in many cell types, such as immune and host defense responses, 
angiogenesis stimulation, tissue remodeling influence (Baud and Karin, 2001), and 
apoptosis promotion via its two receptors, TNF-RI and TNF-RII (Hengartner et al., 
2000). TNF-α is representative of a still growing family of cytokines and cell 
surface proteins such as lymphotoxin-α(LT-α), Fas ligand (FasL), receptor-
activator of NF-κB (nuclear factor-kappa B) ligand (RANKL), CD40 ligand (CD40L) 
and TNF-related apoptosis-inducing ligand (TRAIL), which display 25-30% 
sequence similarity, mostly in residues responsible for their trimerization (Baud 
and Karin, 2001). Studies revealed the location of FasL receptor in 
syncytiotrophoblasts, whereas FasL has been reported in villous cytotrophoblast 
cells in the first trimester placentas (Huppertz et al., 1998). Other studies proposed 
FasL in both cellular layers of trophoblasts through gestation (Runic et al., 1996; 
Zorzi et al., 1998). Interestingly, mice with a mutated FasL gene express a 
dysfunctional protein. During pregnancy, namely on day 10, the placentas of these 
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mice exhibited leukocyte infiltration and necrosis at the feto-maternal interface, 
suggesting how a functional FasL became very important at midgestation (Hunt et 
al., 1997). Controversial is the cause and effect relationship. Although the 
pregnancy outcome in these animals is always associated to death because of 
placental disintegration, it is still not clear if this is due to immune cells attack or if it 
could stimulate leukocytes infiltration. In pregnancy-related studies, TNF-α was 
identified in the ovary, oviduct, uterus and placenta (Terranova et al., 1995), and 
seems to be expressed also in embryonic tissues at all stages of development 
(Kohchi et al., 1994). Moreover, TNF-α together with TNF-α-like factors, 
represents a key factor in normal processes such as cell renewal or tissue 
homeostasis (Hunt et al., 1992, 1996), and during implantation, this multifunctional 
cytokine ensures a correct attachment of the blastocyst to the uterine wall by 
creating the right inflammatory environment (Sharkey, 1998; Ashkar et al., 1999, 
2000). In fact, during early pregnancy, the uterine epithelium undergoes apoptosis, 
and regression of decidual cells coordinates trophoblast invasion. The apoptotic 
degeneration of the maternal tissue seems to be mediated by TNF-receptor 1 
(Joswig et al., 2003). Several investigations proposed TNF-α as being involved in 
pregnancy failure. High levels of TNF-α in amniotic fluid are associated with 
infection or preterm labour (Romero et al., 1989). Studies showed that 
administration of lipopolysaccharide (LPS) to pregnant animals causes abortion, 
since LPS, an endotoxin and component of the cell-wall of gram-negative bacteria, 
binds to its receptors and sends a powerful stimulus for secretion of cytokines, 
such as TNF-α, by macrophages which induces pregnancy failure (Silver et al., 
1994). Moreover, in the abortion murine combination CBA/J x DBA/2J, increased 
level of TNF-α as well as IFN-γ cytokines were observed when compared to the 
controls (Tangri and Raghupathy, 1993; Clark et al., 1999; Raghupathy, 2001, 
Fest et al., 2006) and proposed as a cause of abortion. TNF-α is a potent factor, 
which exerts positive and negative effects during pregnancy. This factor´s 
intriguing dichotomy together with its powerful ability in triggering apoptosis via its 
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1.5.3 Successful or failed pregnancy outcome: the Th1/Th2/Th3 paradigm 
T helper lymphocytes (Th lymphocytes) CD4+ can be divided into subsets of cells, 
Th1 and Th2 lymphocytes, differing in pattern of cytokine production and in the 
role during immune response (Raghupathy, 2001). Th1 cells are involved in the 
regulation of cellular immunity by secreting Th1 or pro-inflammatory cytokines 
such as interleukin –1, IL-1, IL-2, IL-6, IL-12, IL-15, IL-18, interferon gamma, IFN-γ 
or tumor necrosis factor, TNF-α, whereas Th2 cells play a role in humoral 
response activation by secreting Th2 or anti-inflammatory cytokines like IL-4, -5, -
10 and IL-13 (Mosmann et al., 1989, 2005). The existence of a third group, 
denominated Th3, involved in the secretion of TGF-β with suppressive activity 
toward Th1 response, was proposed by Chen and colleagues (1994). During 
pregnancy, an additional source of cytokines is represented by those cytokines 
secreted by decidual epithelium and stroma, cyto- and syncytiotrophoblast cells, 
chorion, amnion and uterine natural killer cells (uNK). The cytokines secreted by 
these cells are also defined as type 1 or type 2 reactivity (Mosmann and Sad, 
1996), although it is usual to describe them as Th1/Th2. Cytokines originating from 
these tissues take part in induction of maternal tolerance towards fetal allograft, 
regulate local immunity against infective factors, modulate placental hormonal 
production and tissue remodeling during trophoblast invasion (Guilbert et al., 1993; 
Robertson et al., 1994; Bennet et al., 1998). An appropriate cytokine balance at 
the feto-maternal interface during different stages of gestation is thought to be 
fundamental to avoid fetal rejection (Wegmann et al., 1993; Clark et al., 1999; 
Raghupathy et al., 1997, 1999). The imbalance between pro- and anti-
inflammatory cytokines towards an inflammatory profile is thought to be involved in 
reproductive failures in humans as well as in mice (Clark et al., 1999; Raghupathy 
et al., 1997, 1999). In this sense, it has been proposed under the definition of 
“Th1/Th2/Th3 paradigm” that a Th2-Th3 type response could be associated with 
successful pregnancy (Lin et al. 1993, Chaouat et al., 1995; Raghupathy, 2001) 
while the prevalence of an inflammatory response, i.e. a Th1-type response, would 
not allow the fetus to survive (Lin et al., 1993; Krishnan et al., 1996a; Zenclussen 
et al., 2003a). The possible positive role of a switch to Th2 cytokines during 
pregnancy was proposed after observing that injection of Th1 cytokines (such as 
TNF-α, IFN-γ and IL-2) into pregnant mice causes abortion (Clark et al., 1999), 
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whereas up-regulation of IL-10 could prevent naturally occurring fetal loss in 
CBA/J x DBA/2J combination (Chaoaut et al., 1995). Moreover, gestional tissues 
harvested from mice undergoing spontaneous abortion showed a Th1 cytokine 
bias (Clark et al., 1999), whereas placental IL-10 production is low in abortion-
prone crossing of mice (CBA/J x DBA/2J; Clark et al., 1999). Nevertheless, 
recently published data indicated that the Th1/Th2 cytokine ratio might not be the 
overall explanation for successful reproductive outcome, but a way to simplify 
(Svensson et al., 2001; Zenclussen et al., 2002a; Chaouat et al., 2003). Moreover, 
mice lacking both functional genes for IL-4 and IL-10 have normal litter sizes 
confirming that the Th1/Th2 ratio may not be as important as it was thought in the 
´90s (Svensson et al., 2001). Recently, Barber and colleagues (2005) reported 
that Th1 cytokines such as TNF-α and IFN-γ  are synthesized in the placenta in 
response to Lysteria monocytogenes infection, in order to eradicate this pathogen. 
Their data showed a requirement for Th1 cytokines during pregnancy to combat 
infections. Generally, it is accepted that local changes in the balance of Th1/Th2- 
cytokine profiles occurring during pregnancy within the maternal uterus and at the 
feto-maternal interface, contributes to implantation, placental development, fetal 
survival and immunity.  
 
1.5.3.1. Th1 activity during pregnancy 
Th1 cytokines, although harmful during mid gestation, are necessary at the early 
stages of pregnancy (Ashkar et al., 1999, 2000; Saito et al., 1999). After 
attachment of the blastocyst to the uterine epithelium (implantation), embryonic 
signals initiate the process of decidualization, in order to ensure placental 
development. Implantation itself is totally dependent on the presence of pro-
inflammatory cytokines such as IL-1, TNF-α and IFN-γ (Sharkey, 1998; Ashkar et 
al., 1999, 2000) as well as the leukemia inhibitory factor (LIF), a pleiotropic 
cytokine first identified by Hilton (1988), which is up-regulated in mice on day 4 of 
pregnancy, just before implantation (Bhatt et al. 1991). LIF deletion in mice causes 
abnormal decidualization, uterine stroma remodeling and implantation defects 
(Stewart et al.,1992). Despite fundamental in the early stage of fetal development, 
pro-inflammatory cytokines seem to be involved in pregnancy failure (Wegmann et 
al., 1993; Raghupathy, 1997, Clark et al., 1999). Tangri and Raghupathy (1993) 
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showed that high TNF-α and IFN-γ levels were present in the uteri of aborting 
CBA/J x DBA/2J mice compared to normal pregnancy controls, and Wegmann 
(1993) realized that these two cytokines (TNF-α and IFN-γ) are the more 
representative involved in the onset of abortion. Recently, Fest and colleagues 
reported TNF-α as a crucial cytokine mediating abortion after stress application or 
Substance P injection (Fest et al., 2006). Chaouat and colleagues (1995) 
described a significant decrease in Th2 cytokines by decidual cells in the CBA/J x 
DBA/2J abortion combination compared to pregnant CBA/J females previously 
mated with BALB/c mice. Additionally, IL-6 is augmented in abortion-prone mice 
as compared to normal pregnant mice (Zenclussen et al., 2003a). Despite several 
works pointing to the relevance of Th1 cytokines in causing abortion if elevated, 
novel data suggest that Th1 augmentation alone does not explain abortion as Th1 
cytokines seem to be essential for placental immunity, such as against 
L.monocytogenes infection (Barber et al., 2005). Further, Zenclussen and 
colleagues (2002a) described augmented IL-12 in blood from normal pregnant 
women as compared to non-pregnant age-matched women. Patients prone to 
miscarriage, on the contrary, have lower IL-12 levels compared to normal pregnant 
individuals. Chaouat later reported increased levels of Th1 cytokine IL-18 in 
abortion-prone mice as compared to normal pregnant mice (Chaouat et al., 2003). 
 
Nowadays, it is well known that Th1 activity is necessary for implantation to occur 
as well as for the regulation of placentation and defense against infection. 
However, if for some reason augmented they may compromise pregnancy. 
 
1.5.3.2. Th2 activity during pregnancy 
Trophoblast, decidua, chorionic and amniotic membranes are all the source of Th2 
cytokines and TGF-β (Roth et al., 1996; Bennett et al., 1998). Wegmann and 
colleagues (1993) proposed for the first time that during pregnancy Th1/Th2 
activity balance is strongly shifted towards Th2 activity (the so called “Th2 
phenomenon”). Accordingly, an increased Th1 activity is incompatible with 
successful pregnancy. The role of Th2-type cytokines in reducing abortion was 
demonstrated by Chaouat (1995), who showed that placentas from resorption-
prone CBA/J x DBA/2J mice produced less IL-4 and IL-10 compared to placentas 
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from normal pregnant mice. Moreover, this study revealed that administration of 
Th1 activity inhibitors, such as antibodies against IFN-γ or exogenous Th2 
cytokines (IL-3 or IL-10) protect the embryos from rejection. Krishnan and 
colleagues (1996 a,b) infected pregnant and non-pregnant C57BL/6 mice with the 
parasite Leishmania major. Only pregnant mice, in which the Th1 response was 
physiologically suppressed although not totally abrogated, could not clear the 
infection. On the contrary, non-pregnant mice were fully recovered by a strong Th1 
type cells response. These studies supported the concept of a maternal Th2 
immune response during successful pregnancy. On the other hand, other studies 
showed that IL-4 and IL–10 knock-out mice have normal pregnancy, pointing out 
that these cytokines, despite their proven protective role during pregnancy, are not 
essential for successful completion of gestation, thus re-questioning their 
importance (Svensson et al., 2001). 
 
1.6. Pregnancy-protective molecules: heme oxygenase enzymes (HO) 
1.6.1. Overview 
The heme oxygenase (HO) enzymes were originally characterized in 1969 
(Tenhunen et al.) as responsible for the heme degradation into bilirubin and CO. 
HO has been proposed to have tissue-protective properties by avoiding toxic 
accumulation of free heme from damaged red blood cells. Studies described HO 
being involved in the control of vascular tone (Christova et al., 2000), regulation of 
anti-inflammatory processes (Sass et al., 2003; Song et al., 2003) and anti-
apoptotic responses (Soares et al., 1998; Brouard et al., 2000; Ke et al., 2002; 
Song et al., 2003). HO is also responsible for the reduction of oxidative stress and 
subsequent tissue damage in several organ systems (Siow et al., 1999; Masini et 
al., 2003). Three forms of HO such as HO-1, HO-2 and HO-3 were identified 
(reviewed in Montellano, 2000). HO-1 is a 32 KDa, highly induced by several 
factors, like some pro-inflammatory Th1-type cytokines (Terry et al., 1998), ultra 
violet radiations (Keyse et al., 1989), oxidative stress (Applegate et al., 1991), and 
hypoxia (Maines, 1997), therefore coined as a “stress protein”. On the contrary, 
HO-2, a protein of 36 KDa, does not seem to be inducible (Montellano, 2000). 
However, it is known that HO-2 is inducible in reproductive tissues such as 
placenta and decidua (Lyall et al., 2000; Zenclussen et al. 2003b, 2005a). HO-2 is 
found in numerous tissues throughout the body, and appears to be involved in the 
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maintenance of basal heme metabolism (Elbirt and Bonkovsky, 1999). HO-3 
represents a less characteristic and active of the three forms (Maines 1997; 
McCoubrey et al., 1997), which might have a regulatory role in heme-dependent 
cellular processes (McCoubrey et al., 1997). HO-1 is ubiquitously distributed in 
mammalian tissues but expressed in high concentrations in spleen and liver, areas 
having an increased erythrocyte turnover (Elbirt and Bonkovsky, 1999). 
Interestingly, heme oxygenase is expressed at high concentrations in the placenta 
(Ihara et al. 1998, Zenclussen et al. 2005a). Free heme can undergo auto-
oxidation to produce superoxide (O-2) and hydrogen peroxide (H2O2), which may 
promote the formation of highly toxic reactive oxygen species (ROS), therefore HO 
is recognized as anti-oxidant by removing free heme (Montellano, 2000). In 
addiction, biliverdin and Fe2+ (second and third catalytic products of heme 
degradation) contribute to the HO oxidant effect. Inadequate HO-1 expression 
represents a common event in the pathogenesis of inflammatory diseases like 
endotoxic and septic shock (Cohen, 2002) as well as atherosclerosis (Libby, 
2002), coronary artery disease, abdominal aortic aneurysm, myocardial infarction, 
chronic rejection of transplanted organs (Bach et al., 2005) or autoimmune 
diseases such as arthritis or multiple sclerosis (Nathan, 2002). Moreover, there is 
convincing evidence that the up-regulation of HO-1 allows the acceptance of 
mouse allograft (Soares et al., 1998; Woo et al., 1998; Araujo et al., 2003), and 
protects tissues from oxidative injury (Agarwal et al., 1995; Lee et al., 1996; Poss 
et al., 1997). 
 
1.6.2. Heme oxygenases: protective effects during pregnancy 
Taking into consideration the role of heme oxygenases in transplantation, and the 
fact that the fetus could be considered a semi-allograft within the maternal uterus 
(Medawar, 1953), our group has hypothesized that in pregnancy, HO enzymes 
may be involved in tolerance towards the semiallogeneic fetus. Considering that 
placenta transports a huge amount of oxygen, it is very probable that HO plays a 
determining role during pregnancy (Zenclussen et al. 2003b, 2005a; Sollwedel et 
al., 2005; Zenclussen M.L. et al., 2006). This would ensure the correct 
development of the fetus within maternal uterus. Recent studies reported 
diminished expression of both isoforms, HO-1 and HO-2, at the feto-maternal 
interface from mice undergoing Th1-mediated abortion compared to normal 
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pregnant mice, suggesting a protective effect of heme oxygenases in allogenic 
murine pregnancy maintenance (Zenclussen et al., 2002b, 2005). Moreover in 
humans, a significant reduction of both HO-1 and HO-2 expression has been also 
revealed in placenta samples from patients with pregnancy complications as 
compared to normal pregnant women (Barber et al., 2001; Zenclussen et al., 
2003b). A hypothetical scenario nicely proposed by Zenclussen and colleagues 
(Fig. 5; 2002b) compares the different regulations of HO in the case of normal 
pregnancy or abortion. Here, in the situation of pregnancy failure, diminished 
levels of HO-1 in decidual cells, trophoblast and/or endothelial cells would lead to 
augmented levels of free heme, which is per se toxic, further allowing pro-













Fig. 5 Hypothetical scenario showing how down-regulated levels of HO could be implicated in the 
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1.7. Apoptosis 
1.7.1. Cell death: history and types 
A cell can – and often does - kill itself through a process known as apoptosis or 
programmed cell death (PCD). This capacity is essential during development, 
defense as well as in maintaining of tissue homeostasis. PCD is defined as cell 
death that occurs at a specific point in development (and is, therefore, 
“programmed”, Zhang et al., 2003). The interest in cell death began in the middle 
of the 19th century with some morphological observations. Then, in 1972, the 
Australian pathologist J.F.R Kerr and his Scottish colleagues A.H. Wyllie together 
with A.R. Curie described a similar death in mammals, affecting individual cells 
within a tissue. They observed how certain dying cells share a number of common 
morphologic features and how apoptosis observed during development is the 
same process happening in mature organisms and continuing throughout life. 
They coined the term apoptosis derived from the Greek “apoptein” (αpiοpiτειν), 
meaning “dropping off”, as in the dropping off of flower petals or falling leaves 
(Kerr et al., 1972; Wyllie et al., 1980), to distinguish it from necrosis (νεκροσισ, 
meaning in Greek “make dead”). Apoptosis and necrosis are two forms of cell 
death, clearly distinct from each other by different morphological as well as 
biochemical events (Table 1; Wyllie et al., 1980). Necrosis is induced accidentally 
by injury and exhibits early lysis of the plasma membrane before any significant 
alterations in nuclear morphology, whereas apoptosis is a genetically controlled 
event defined by a specific pathway pattern leading to characteristic cell shrinkage 
together with nuclear and cytoplasmatic changes (Wyllie et al., 1980; Liu et al., 
1997; Kothakota et al., 1997; McPherson and Goldberg, 1998). Apoptosis and 
necrosis can take place simultaneously in tissues or cells exposed to the same 
stimulus (Shimizu et al., 1996), although often the intensity of the initial insult 
decides which event will prevail over the other (Bonfoco et al., 1995). Interestingly, 
apoptosis in response to lack of adhesion or inappropriate adhesion has been 
termed anoikis (a Greek word meaning “homelessness”); it represents the 
programmed cell death of anchorage-dependent cells that detach from the 
extracellular matrix (ECM, Frisch and Francis, 1994). Usually cells stay close to 
each other in order to constitute the tissue, which they belong to. The 
communication between proximal cells as well as between cells and ECM 
provides an essential signal for growth or survival, therefore, when cells are 
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detached from the ECM, they undergo apoptosis. All the features characterizing 
apoptosis, including nuclear fragmentation and membrane blebbing, are observed 
during anoikis. Chipuk and Green (2005) described another type of cell death, 
called caspase-independent cell death (CICD), occurring when a signal that 
normally engages apoptosis fails to activate caspases, but the cell, nevertheless, 
dies. This kind of death is induced as defined for apoptosis, but in absence of 
caspase activity to dissemble the cell. Operationally, this is usually seen when 
caspase inhibitors are present or when the pathway is genetically disrupted. CICD 
does not resemble apoptosis; in particular there is no chromatin condensation, 
DNA fragmentation or cellular blebbing. In the following table the main features of 
three types of cell death (apoptosis, necrosis and caspase-independent cell death) 




  Summary of the features distinguishing and characterizing the three cell death types, from 





Target APOPTOSIS NECROSIS CASPASE-INDEPENDENT CELL DEATH 
Nucleus 
Cleavage of caspase 
targets 
DNA laddering 
Nuclear envelop alterations 
Fragmentation of nuclei 
Chromatin condensation 
  
 DNA random fragmented 
 
Partial chromatin condensation 
Marginalization of chromatin around nuclear 
membrane 
No DNA laddering 
Shrinkage of nucleus 




Cleavage of caspase 
targets 
Loss of membrane 
potential 
 Mitochondrial swelling 
 
Outer membrane swollen or absent 
Membrane potential present 
Cytoplasm 
Cleavage of caspase 
targets 
Condensation 
Increase of [Ca2+] 
Protein cross-linking 
Dilatation of endoplasmic 
reticulum 
Decrease of [Ca2+] 
 
Vacuolated 
No controlled organelles break-down 
Darkened cytoplasm 
Aggregation of ribosome 
Plasma 
membrane 




Annexin V positive 
 Fall down of ionic transport 
 Swelling 
 Membrane lysis 
Propidium Iodide positive 




Loss of proliferation 
capacity 
Cell detachment from 
matrix 
Apoptotic bodies formation  
Phagocytosis of dying cell 
 Any immune response 
activation 
Slow event (max 24 hours) 
Active process requiring 
ATP 
Release of cytoplasmic content 
in the extracellular space 
More cells involved 
 Immune response activation 
Fast event (minutes) 
Passive process not requiring 
ATP 
Loss of proliferation capacity 
No apoptotic bodies present 
Cells often remain attach to the matrix 
Cells are removed by unknown mechanisms 
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1.7.2. Features 
1.7.2.1. Phases characterizing apoptosis 
Programmed cell death plays a determining role in many biological mechanisms 
such as that involved in construction, maintenance and repair of tissues. In animal 
development, apoptosis is essential for establishing tissue architecture (Meier et 
al., 2000; Yuan and Yankner, 2000), whereas in the immune system it is the most 
common form of death, regulating lymphocyte maturation, receptor repertoire 
selection and homeostasis (Green, 2003). Apoptosis derailment is involved in 
severe diseases such as autoimmunity or cancer, where immune cells fail to die 
due to an over-expression of bcl-2 (an anti-apoptotic gene) and/or under-
production of Fas (death receptor; Krammer, 2000). On the other hand, acquired 
immunodeficiency syndrome (AIDS) is characterized by too much apoptosis 
leading to a depletion of CD4+ T helper cells, called immunodeficiency (Krammer, 
2000). Apoptosis exists as a mechanism to remove cells. This process could be 
result of infected or damaged cells, or when there are excessive quantities of cells 
or they have failed a developmental “test”, or simply because their presence is no 
longer required for physiological processes. There are several inductors involved 
in apoptotic activation such as glucocorticoids (Wyllie et al., 1980), DNA-damaging 
agents (ionizing, radiations, chemo-therapeutic or methylating agents), reactive 
oxygen species (ROS) and lack of survival signals (Hengartner, 2000). This first 
phase is called induction phase and is followed by an effector phase, representing 
a point of no-return, since the numerous apoptotic stimuli converge into two main 
pathways (intrinsic or extrinsic, death cell receptor or mitochondrial respectively) 
involving proteases called caspases (cysteine proteases with specificity for 
aspartate residues), are no longer reversible. Degradation phase occurs whereby 
the cellular functions and structures begin to get destroyed, giving rise to a full-
blown phenotype (apoptotic bodies) which will be further completely engulfed by 
macrophages or neighbor cells (Hengartner, 2000). 
 
1.7.2.2. Pathways inducing apoptosis 
Depending upon the stimuli, apoptosis can be initiated by one of two pathways: 
the death receptor mediated (extrinsic) or mitochondrial pathways (intrinsic). It was 
suggested that these two were independent of each other, then it has been 
demonstrated that Bid, a member of Bcl-2 family proteins, serves as a link 
 - 34 - 
between the two for completing apoptosis (Li et al., 1998, Luo et al., 1998). The 
nematode Caenorhabditis elegans has been a good model organism for deeply 




 Death receptor-mediated pathway 
The death receptor-mediated pathway - or extrinsic pathway - is triggered by 
members of the death-receptor super-family (e.g. CD95, also called Fas or Apo-1), 
and tumor necrosis factor receptor I or II (TNF-RI or TNF-RII, respectively; 
Ashkenazi and Dixit, 1998). The signal is provided by interaction between specific 
ligands (e.g. FasL/CD95L and TNF-α) and their death receptors on the cellular 
membrane, leading to receptor clustering induction and formation of the death-
inducing signaling complex (DISC). The members of the death receptor family 
contain five cysteine-rich repeats in their extracellular domain and a death domain 
(DD) in their cytoplasmic tail. The DD is essential to initiate the apoptotic signal 
(Danial and Korsmeyer, 2004). After ligand-receptor binding, the death receptor 
oligomerizes and DISC recruits, via the adaptor proteins FADD (Fas-associated 
death domain) and TRADD (TNFR-associated death domain), inactivated 
uncleaved pro-caspase-8 molecules, resulting in its activation (Danial and 
Korsmeyer, 2004). Once cleaved, this initiator caspase is able to generate active 
effector caspases (-3, -6, and -7), which cleave a number of target substrates. In 
particular, caspase-3 plays a major role in disassembly of the nucleus by 
processing several nuclear substrates, being actively transported to the nucleus 
through the nuclear pores (Faleiro and Lazebnik, 2000). The death receptors and 
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Fig. 6 The distinct composition of the Death-Inducing-Signaling Complex (DISC) downstream of 
the various death receptors TNFR1, CD95, and DR4/5 (from Danial and Korsmeyer, Cell, 2004). 
 
 Mitochondrial pathway 
A number of stimuli, including chemotherapeutic agents, UV radiations, so-called 
stress molecules (i.e. reactive oxygen and reactive nitrogen species) and growth 
factor withdrawal appear to mediate apoptosis via the mitochondrial pathway, a 
death receptor-independent way (Hengartner, 2000). The inner membrane of 
mitochondria contains ATP synthase, electron transport chain and adenine 
nucleotide translocator (ANT). Under physiological conditions these molecules 
allow the respiratory chain to create an electronic gradient (membrane potential). 
On the other side, the outer membrane contains a voltage-dependent anion 
channel and its permeabilization results in the release of the molecules stored in 
the intermembrane space such as cytochrome c, procaspases, kinases, 
Smac/DIABLO (second mitochondrial derived activator of caspase/direct IAP 
binding protein with low pI), which blocks the function of IAP (inhibitor of apoptosis 
protein) and apoptosis-inducing factor, AIF. The release of cytochrome c in the 
cytoplasm is one of the major steps in the mitochondrial pathway, associated with 
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permeabilization of the outer membrane, since it promotes the apoptosome 
formation, constituted by cytochrome c, apoptotic protease-activating factor, Apaf-
1 (Cain et al., 1999), and procaspase-9, which in turn activates executioner 
caspases to orchestrate apoptosis. Mitochondria are an important component of 
the endoplasmic reticulum (ER) stress-induced apoptotic pathway. ER regulates 
apoptosis by sensitizing mitochondria (i.e. via stress agent releasing) to a variety 
of extrinsic and intrinsic death stimuli or by initiating cell demise signals of its own 
(Breckenridge et al., 2003). The mechanism by which ER stress is coupled to 
activation of caspases is still unclear, but it is known that caspase-12 
(characterized by Nakagawa and Yuan, 2000), localized at the cytosolic face of 
ER, is remarkably specific to insult that elicits ER stress and is not proteolytically 
activated by other death stimuli (Nakagawa et al., 2000). As a matter of fact, 
caspase-12 null mice or cells are partially resistant to apoptosis induced by ER 
stress but not by other apoptotic stimuli, pointing to the specificity of caspase-12 
for ER (Nakagawa et al., 2000). In Fig. 7 the two pathways (death receptor 
mediated and mitochondrial) leading to apoptosis have been summarized in order 

















Fig. 7 Two major apoptotic pathways are illustrated: one activated via death receptor activation 
('extrinsic') and the other by stress-inducing stimuli ('intrinsic'). Triggering of cell surface death 
receptors of the tumour necrosis factor (TNF) receptor superfamily, including CD95 and TNF-
related apoptosis-inducing ligand (TRAIL)-R1/-R2, results in rapid activation of the initiator caspase 
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8 after its recruitment to a trimerized receptor-ligand complex (DISC) through the adaptor molecule 
Fas-associated death domain protein (FADD). In the intrinsic pathway, stress-induced apoptosis 
results in perturbation of mitochondria and the ensuing release of proteins, such as cytochrome c, 
from the inter-mitochondrial membrane space. The release of cytochrome c, from mitochondria is 
regulated in part by Bcl2 family members, with anti-apoptotic (Bcl2/ Bcl-XL/Mcl1) and pro-apoptotic 
(Bax, Bak and tBid) members inhibiting or promoting the release, respectively. Once released, 
cytochrome c binds to apoptotic protease-activating factor 1 (Apaf1), which results in formation of 
the Apaf1−caspase 9 apoptosome complex and activation of the initiator caspase 9. The activated 
initiator caspases 8 and 9 then activate the effector caspases 3, 6 and 7, which are responsible for 
the cleavage of important cellular substrates resulting in the classical biochemical and 
morphological changes associated with the apoptotic phenotype (from MacFarlane and Williams, 
EMBO Reports, 2004). 
 
 
1.7.2.3. Caspases: natural born killers 
Caspases are cysteine proteases, sharing similarities in amino acid sequence, 
structure and substrate specificity, with a critical cysteine residue in their active 
site, which, if mutated, is consequentially connected with the loss of the activity 
(Cohen et al., 1997; Nicholson, 1999). Caspases can be divided into two main 
classes: initiator and effector caspases (Thornberry and Lazebnick, 1998). Initiator 
caspases (such as caspase 8, if activated by death receptors, or 9, if the death is 
induced by toxic agent) are upstream of effector caspases (like caspases 3, 6, 7) 
defined as the executioners in the cell because, cleaving other proteins, they lead 
to morphological features as membrane blebbing, cytoplasmic and nuclear 
condensation, DNA fragmentation, and formation of apoptotic bodies (Hengartner, 
2000). The caspase cascade leads to irreversible cell suicide. The proteolytic 
activity of caspases targets several subsets of proteins involved in homeostasis, 
repair and structure of cells (Hengartner et al., 2000). These proteins can be 
summarized in the following groups: a.) Enzymes involved in genome repair, i.e. 
poly (ADP-ribose) polymerase (PARP), which was the first protein identified as a 
substrate for caspases, cleaved by caspase-3 prior to the degradation of nuclear 
DNA into fragments (Kaufmann et al., 1993); b.) Enzymes involved in cell 
replication and cell cycle progression, i.e. the inactivation of DNA topoisomerase II 
by caspases interferes with DNA function (McPherson and Goldberg, 1998); c.) 
DNA. The characteristic internucleosomal fragmentation of DNA associated with 
apoptosis (Wyllie, 1980) is triggered by caspase-activated deoxyribonuclease 
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(CAD) enzyme (Liu et al., 1997); d.) Nuclear and cytoskeletal proteins. Caspase-6 
degrades laminins and this results in chromatin condensation and nuclear 
fragmentation; caspase-3 cleaves gelsoline in the cytoplasm which disrupts actin 
filaments leading to an altered cytoplasmic architecture (Kothakota et al., 1997); 
e.) Cell membranes and matrix attachment. Caspases-3 and -6 cleave focal 
adhesion kinase (FAK), disrupting cell adhesion irreversibly and interfering with 
transmission of matrix-derived cell survival signals (Wen et al., 1998). 
 
1.7.2.4. The Bcl-2 family 
Bcl-2 and related cytoplasmic proteins are key regulators of apoptosis. The 
mammalian Bcl-2 family consists of both, pro- and anti-apoptotic proteins, which 
show sequence and structural similarity in the Bcl-2 homology (BH) regions. The 
proteins of the Bcl-2 family inhibit or promote the death process by their ability to 
modulate mitochondrial homeostasis (Gupta, 2003). Several family members were 
identified (Cory and Adams, 2002), which were divided into three subfamilies: 
 
a. Bcl-2 subfamily (anti-apoptotic): Bcl-2, Bag-1, Bcl-xL, Bcl-w, Mic and A1; 
b. Bax subfamily (pro-apoptotic): Bax, Bak and Bok; 
c. BH3 subfamily (pro-apoptotic): Bad, Bak, Bcl-xS, Bid, Bik, Hrk, BNIP3 
and BimL; 
 
The Bcl-2 family can be defined by the presence of conserved motifs known as 
Bcl-2 homology domains (BH1 to BH4). While Bcl-2 and its homologs (Bcl-xL, Bcl-
w, Mic and A1) contain all four BH domains, the Bax subfamily is constituted at 
least by BH1 and BH2. The BH3 subfamily members possess only the central 
short (9-16 residue) BH3 domain and are unrelated to any known protein. Some 
members of the Bcl-2 family are also characterized by dimerizing to further 
modulate apoptosis; Bag 1, for example, has been found to form a heterodimer 
with Bcl-2 resulting in the enhancement of the anti-apoptotic effect of Bcl-2 
(Hengartner, 2000; Cory and Adams, 2002). Bax and Bak have been shown to 
play a critical role in cytochrome c release from mitochondria and thus initiating 
apoptosis (Hengartner, 2000; Cory and Adams, 2002). Bad plays a critical role in 
the Bax-mediated apoptosis pathway by dimerizing with Bcl-xL, causing the 
displacement of Bax, which allows apoptosis to proceed. Bcl-xS, a shorter version 
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of Bcl-x (lacking amino acids 126-188), apparently utilizes a different pathway than 
Bax to induce cell death (Cory and Adams, 2002). Pro-apoptotic members, 
including Bax, Bak, Bid, Bim, promote activation of death-inducing proteins, such 
as cytochrome c from mitochondria, while anti-apoptotic molecules, such as Bcl-2 
and Bcl-xL, inhibit this release (Grinberg et al., 2002; Gross et al., 2002). Following 
activation, these death-inducing proteins promote apoptotic cell destruction 
through multiple pathways including caspase activation and nuclear DNA 
fragmentation (Hengartner, 2000). It has been suggested that Bax can form a 
transmembrane pore across the outer mitochondrial membrane, leading to loss of 
membrane potential and efflux of cytochrome c and apoptosis-inducing factor (AIF; 
Hengartner, 2000). It is thought that Bcl-2 and Bcl-xL act preventing this pore 
formation. Heterodimerisation of Bax or Bad with Bcl-2 or Bcl-xL is thought to 
inhibit their protective effects (Cory and Adams, 2002).  
 
1.7.3. Apoptosis and pregnancy 
Programmed cell death, along with cell proliferation and differentiation, plays 
crucial roles during normal embryogenesis (Joswig et al., 2003). Pregnancy loss 
and the occurrence of inborn structural anomalies are often preceeded by 
excessive apoptosis in targeted embryonic and extra-embryonic tissues (Toder et 
al., 2002). Apoptosis has also been demonstrated in normal placenta throughout 
pregnancy as responsible for its growth and remodelling, in balance with the cell 
proliferation (Smith et al., 1997). Studies have shown the expression of Bcl-2 
protein in syncytiotrophoblast cells, an expression that is  abundant in very early 
placenta, less abundant in midterm placenta and least abundant in term placenta 
(Maruo et al., 2001). These observations indicate that very early placenta is 
characterized by highly proliferative activity of syncytiotrophoblast cells associated 
with increased occurrence of apoptosis. During the initial steps of mouse 
implantation, the uterine epithelium of the implantation chamber undergoes 
apoptosis, which is thought to be a response to the blastocyst (Hardy, 1999). With 
progressing implantation, regression of the decidual cells via apoptosis allows a 
restricted and co-ordinated invasion of trophoblast cells into the maternal 
compartment: this invasion represents an extremely important process for 
pregnancy progression. The analysis of apoptosis in murine uterine epithelium and 
decidua during early pregnancy (days 4.5 – 7.0) revealed an important function for 
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apoptosis, as Bax (pro-apoptosis) and Bcl-2 (anti-apoptosis) show a 
complementary expression pattern with Bax in the primary and Bcl-2 in the 
adjacent decidual zone (Gu et al., 1994).  
 
In this work we investigated whether miscarriage was preceded by augmented 
apoptotic rates. Therefore, the incidence of apoptosis has been studied in a well-
known experimental model of immunological abortion, such as the murine 
combination CBA/J x DBA/2J, which presents increased local TNF-α levels at the 
feto-maternal interface (Tangri and Raghupathy, 1993; Clark et al., 1999; 
Raghupathy, 2001).  
On the other hand, we focused our attention on heme oxygenase-1 (HO-1). 
Considering HO-1 anti-apoptotic properties, we examined if the protective effects 
of up-regulated HO-1 leading to successful pregnancy could be related to changes 
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2. Aims of the study 
 
2.1. To investigate whether the apoptotic rate was different in abortion-prone 
mice compared to normal pregnant animals 
Based on the evidence that murine abortion is characterized by excessive type-1 
cytokine production (Wegmann et al., 1993; Raghupathy, 1997) and diminished 
Th2 cytokine levels (Chaouat et al., 1995), and taking into account that TNF-α is 
an important apoptosis inductor (Gupta, 2002), we aimed to investigate whether 
abortion was preceded by augmentation in the apoptotic rates. To carry out this 
study, we analysed the activity of a key enzyme of programmed cell death, namely 
the caspase-3, which activation represents a point of no return in apoptosis 
induction. We also studied another important hallmark of programmed cell death 
such as the DNA fragmentation. Additionally, several anti- and pro- apoptotic 
molecules involved in cell death pathways were identified at the feto-maternal 
interface and quantified to study their participation in the onset of pregnancy 
failure. 
 
Thus, in abortion-prone mice compared to normal pregnancy controls we 
analysed:  
 
I. The ability of immune cells isolated from decidua to produce Th1 or Th2 
cytokines after PMA/Ionomycin 
Local changes to the balance of Th1/Th2-type cytokines occur during pregnancy 
within the maternal uterus and at the feto-placental unit. The changes in cytokines 
profiles contribute to implantation (Sharkey, 1998), placental development, and 
fetal survival until birth. In normal pregnancy, the predominant cytokines at each 
stage of gestation are involved in limiting maternal immune rejection of the semi-
allogeneic embryo/fetus, especially at the feto-maternal interface (Clark et al., 
1999; Chaouat et al., 2003). As described in several studies, excessive production 
of pro-inflammatory cytokines (i.e. TNF-α, IFN-γ, IL-6) is strictly correlated to the 
onset of abortion (Wegmann et al., 1993; Clark et al., 1999; Chaouat et al., 2003, 
Zenclussen et al., 2003a). Additionally, Th2 cytokines were reported to be 
protective (Lin et al., 1993; Raghupathy, 1997, 1999; Dealtry et al., 2000). 
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Consequently, the Th1:Th2 ratio plays an important role in pregnancy outcome. 
We measured Th1 and Th2 cytokine secretion (i.e. TNF-α and IL-10) by decidual 
immune cells from abortion-prone and normal pregnant mice using flow cytometry. 
This was performed in order to confirm that fetal rejection is associated to the up-
regulation of pro-inflammatory cytokines also in this experimental setting as 
previously proposed (Raghupathy, 1997; Zenclussen et al., 2003a; Chaouat et al., 
2003). 
 
II. The mRNA levels of TNF-α in placenta as well as in decidua 
A wide range of cytokines involved in the dialogue between mother and its fetus 
are produced during the first period of pregnancy in order to ensure successful 
blastocyst implantation and placental development (Sharkey, 1998; Dealtry et al., 
2000). TNF-α has a potential effect upon implantation and trophoblast invasion by 
regulating integrin expression and function via the TNF-RII (Bowen et al., 2000). 
On the other hand, studies revealed that up-regulation of Th1-type cytokine 
pattern such as TNF-α, IFN-γ or IL-6, is deleterious for a correct fetal development 
(Raghupathy, 1997; Zenclussen et al., 2003a; Chaouat et al., 2003). Knowing that 
TNF-α represents an important signaling molecule in apoptosis via its two 
receptors, TNF-RI and TNF-RII (Bowen et al., 2000), and that its up-regulation is 
associated with fetal rejection (Chaouat et al., 2003), we investigated the TNF-α 
mRNA levels in placentas as well as in decidua from abortion-prone and normal 
pregnancy mice in order to confirm more augmented levels of this pro-
inflammatory cytokine in abortion than in normal pregnant mice as already 
reported in the literature (Clark et al., 1980; Chaouat et al., 1988, 2003; 
Zenclussen et al., 2003a, 2005). 
 
III. The incidence of apoptosis (early and late) in decidual and in spleen 
lymphocytes 
The apoptotic process plays an important role in the development of the immune 
system (Opferman and Korsmeyer, 2003; Green, 2003). Although apoptosis 
participates in the development of a cell lineage, its aberration in immune cell 
could be deleterious, since it is implicated in the initiation of conditions such as 
immune deficiency, autoimmunity and cancer (Vaux and Korsmeyer, 1999). In this 
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work, we investigated the ex-vivo apoptotic rate (early and late) of spleen and 
decidual lymphocytes immune cells by flow cytometry, in order to analyze whether 
resorption is associated with a possible alteration in immune cell apoptosis.  
 
IV. Activity of caspase-3 enzyme in placental homogenates 
Caspases exist as inactive zymogens with an amino-terminal prodomin and two 
subsequently cleaved fragments of about 10 KDa and 20 KDa (p10 and p20) that 
form an active p10-p20 heterotetrameric enzyme (Nicholson, 1999; Cohen et al., 
1997). Initiator caspases such as caspases-8, -9 are involved in transducing 
receptor-mediated and stress-induced death signals, and activate effector 
caspases, such as caspases-3, -6, -7, are responsible for cleavage of many 
cellular proteins during the execution phase of apoptosis (Thornberry and 
Lazebnick, 1998). Moreover, caspase-3 activation represents one of the most 
important signs of whether cells or tissue are undergoing apoptosis (Cohen, 1997). 
We analysed caspase-3 activity in placental homogenates from abortion and 
normal pregnant mice, in order to investigate whether apoptotic activity might be 
modified in whole tissue (immune + non-immune cells) in the pathological situation 
of immunological abortion as compared to normal pregnancy. 
 
V. The DNA fragmentation in placental tissues 
Apoptosis is a multistage process dependent upon a tightly regulated and well-
defined program for its initiation and execution. The terminal morphological and 
biochemical events of programmed cell death are characterized by specific 
changes in cell surface and nuclear morphology (Hengartner, 2000). Nuclear 
morphology changes characteristic of apoptosis appear within the cell together 
with a distinctive biochemical event: the endonuclease-mediated cleavage of 
nuclear DNA, therefore formation of DNA fragments of oligonucleosomal size 
(180-200 bp). The fragmented DNA can be detected by TUNEL (terminal 
deoxynuclotidyltransferase-mediated UTP end labelling) procedure. We analysed 
DNA fragmentation in placental tissues from abortion and normal pregnant mice 




 - 44 - 
VI. Pro- and anti-apoptotic molecules in placental and decidual tissues 
In this study we decided to investigate the role of anti- and pro-apoptotic 
molecules when our analysis revealed no significant incidence of apoptosis in 
abortion-prone mice as compared to the controls. Considering the huge amount of 
molecules involved in programmed cell death, we decided to analysed some of the 
most representative. Bcl-2 acts for one of the bigger players to avoid apoptosis. 
Moreover, its over-expression was proposed to block the apoptosis in pro-B-
lymphocyte cell line (Hockenbery et al., 1990). Another protein with anti-apoptotic 
activity is the BCL-2-associated athanogene-1 protein (Bag-1), whereas Bcl-x, 
whose alternative splicing resulted in a shorter (Bcl-x short, Bcl-xS) or a larger 
(Bcl-xL) mRNA, has antagonist functions: pro- (Bcl-xS) or anti-apoptotic (Bcl-x-L). 
On the other hand, Bax forms homodimers and heterodimers with Bcl-2 in vivo, so 
that when Bax predominates, programmed cell death is accelerated, and the death 
repressor activity of Bcl-2 is countered. Taking these facts into consideration, we 
analysed: 
 
a. The cellular localization of pro- and anti-apoptotic proteins (Bcl-2, Bag-1, 
Bcl-xS and caspase-3) in placental as well as decidual tissues 
 
b. The protein expression of pro- and anti-apoptotic molecules (caspase-3, 
Bcl-xS and Bcl-2, Bag-1) in placental as well as decidual tissues 
 
c. The mRNA levels of mentioned pro- and anti-apoptotic genes in placental 
as well as decidual tissue 
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2.2. To investigate whether the anti-apoptotic properties of HO-1 participate in 
its protective effect during pregnancy 
HSP-32, also known as heme oxygenase-1 (HO-1) is induced following exposure 
to several stressful stimuli, like lipopolysaccharide (Camhi et al., 1995), ultraviolet 
radiation (Keyse et al., 1989), hydrogen peroxide, heavy metal and organic 
chemicals (Keyse et al., 1989). It is known that HO-1 over-expression is involved 
in cardiac xenograft survival (Soares et al., 1998; Araujo et al., 2003). HO-1 and 
HO-2 are down-regulated at the feto-maternal interface in abortion-prone mice 
when compared to normal pregnant mice (Zenclussen et al., 2005a), as well as in 
patients suffering spontaneous abortion during the first trimester, as compared 
with age-matched women undergoing normal pregnancies (Zenclussen et al., 
2003b). Moreover, over-expression of HO-1 by cobalt-protoporphyrin (Co-PP, 
Rosenberg, 1993) injection (Zenclussen et al., 2005; Sollwedel et al., 2005) or by 
adenoviral gene transfer (Zenclussen et al., 2006) improved pregnancy outcome in 
mice undergoing abortion compared to the controls. HO-1 induction is thought to 
be anti-apoptotic in several cell types. Therefore, we aimed to investigate whether 
the HO-1 protective effects for pregnancy were related to changes in the apoptotic 
rate and in the expression of apoptotic-related molecules. 
 
The animals were divided in four groups as previously described (see Methods), 
and thus we analysed:  
 
I. The activity of caspase-3 enzyme in placental homogenates. 
 
II. The DNA fragmentation in placental tissue. 
 
III. The cellular localization of pro- and anti-apoptotic proteins (caspase-
3, Bcl-xS and Bcl-2, Bag-1) in placental as well as in decidual tissue. 
 
IV. The protein expression of pro- and anti-apoptotic molecules (caspase-
3, Bcl-xS and Bcl-2, Bag-1) in placental as well as in decidual tissue. 
 
V. The m-RNA levels of mentioned pro- and anti-apoptotic genes in 
placental as well as in decidual tissue. 
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3. Materials 
 
3.1. Chemicals, Media and Kit. 
AEC, 3-amino-9-ethylcarbazol  DAKO Cytomation, Glostrup, Denmark 
Ampli-Taq DNA polymerase  Eurogentec, Berlin, Germany 
Annexin V FITC conjugated  Sigma, Taufenkirchen, Germany  
aqua ad injiectabilia   Braun, Melsungen, Germany  
Bovine serum albumin (BSA)  Sigma Chemie GmbH, Steinheim, 
Germany 
Caspase-3 colorimetric assay   Sigma, Taufenkirchen, Germany 
Chloroform   Sigma, Steinheim, Germany 
Diamino benzidine (DAB)  Vector Laboratories, Peterborough, 
England 
DNAse   Stratagene, Amsterdam, Niederland 
dNTPs, desoxy–nucleotidtriphosphate  Amersham Biosciences, Freiburg, 
Germany 
DTT, 1,4-Dithio-DL-threitol  FLUKA Biochemika, Sigma, Seelze, 
Germany 
Ethanol absolute   Fluka, Sigma, Seelze, Germany  
Ethylenediaminetetraacetic acid (EDTA)Sigma, Taufenkirchen, Germany 
FBS, fetal bovine serum   Biochrom AG, Berlin, Germany  
Lympholyte-M   Linaris, Bettingen am Main, Germany 
Hank´s Balance Salt Solution (HBSS) Gibco, Invitrogen, Karlsruhe, Germany 
Hematoxilin   Roth, Karlsruhe, Germany 
Histo-Kit   Roth, Karlsruhe, Germany 
H2O2 30%     Merck, Darmstadt, Germany 
HRP Horseradish peroxidase  DAKO, Glostrup, Denemark 
In Situ Cell Death Detection Kit, POD Roche, Mannheim, Germany 
Ionomycin   Sigma, Taufenkirchen, Germany  
L-Glutamine   Gibco, Invitrogen, Karlsruhe, Germany 
Methanol   Baker, Deventer, Holland 
2-Mercaptoethanol   Sigma, Taufenkirchen, Germany 
Monensin   Sigma, Taufenkirchen, Germany  
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NaH4Cl   Merck, Darmstadt, Germany 
Oligo dthymidine-nucleotide (odT)  Amersham Biosciences, Freiburg, 
Germany 
Paraformaldehyde (PFA)   Merck, Darmstadt, Germany  
Penicillin/Streptomycin   Gibco, Invitrogen, Karlsruhe, Germany  
Phorbol-12,13-mystirate (PMA)  Sigma, Steinheim, Germany  
Rainbow marker  New Englands, BioLabs, Frankfurt am 
Main, Germany 
Reverse Transcriptase  Amersham Biosciences, Freiburg, 
Germany 
RNAse-Inhibitor   Protegé, Mannheim, Germany 
RPMI 1640 w L-Glue   Gibson, Invitrogen, Karlsruhe, Germany 
Saponin   Riedel-de Haen, Seelze, Germany 
Sodium azide (NaN3)   Merck, Darmstadt, Germany  
Sodium hydrogen carbonate (NaHCO3) Merck, Darmstadt, Germany 
Sodium pyruvate   Sigma, Taufenkirchen, Germany 
Triphosphate buffered saline (TBS) DULBECCO´S, PAA Laboratories GmbH 
Trizol   Invitrogen, Karlsruhe, Germany  
Trypsin/EDTA+HBSS   Gibco, Invitrogen, Karlsruhe, Germany 
Xylol   Mallinckrodt Baker, Deventer, Holland 
 
 
3.2. Antibodies (Abs)  
• Flow cytometry (all antibodies are monoclonal anti-mouse Abs) 
CD4-FITC (L3T4) clone: H129.19 BD Pharmingen, Heidelberg, Germany 
CD8a-Cy5 (Ly-2) clone: 53-67  BD Pharmingen, Heidelberg, Germany 
TNF-α-PE  clone:  MP6-XT22 BD Pharmingen, Heidelberg, Germany 
IL-10-PE  clone:  JES5-16E3 BD Pharmingen, Heidelberg, Germany 
 
• Immunohistochemistry and western blot 
PRIMARY Abs 
• rabbit anti-mouse Abs 
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Bag-1 (C-16)   Santa Cruz Biotechnology, Heidelberg, 
Germany 
Bcl-2 (N-19)  Santa Cruz Biotechnology, Heidelberg, 
Germany 
Bcl-xS (L-19)   BD Pharmingen, Heidelberg, Germany  
 
• goat anti-mouse Ab 
Caspase-3 p11 (K-19)   BD Pharmingen, Heidelberg, Germany 
 
The antibodies against bcl-xS (L-19) and caspase-3 p11 (K-19) for staining in 
paraffin sections were kindly provided by Dr. Deteyen from Med.Klinik 
m.S.Hepathologie/Gastroenterologie, Virchow Klinikum, Berlin 
 
SECONDARY Abs 
biotinylated antibody goat anti-rabbit Vector, Peterborough, UK 




Assay buffer 10 x (casp.3 activity) 20 mM HEPES pH 7.4, 2 mM EDTA, 0.1% 
CHAPS, 5 mM DTT (1 x in mq water); 
Binding buffer (Annexin-V)  25 mM CaCl2, 1.4 M NaCl, 0.1 M Hepes/NaOH 
pH 7.4 
Blocking-buffer (WB)   5 % milk powder in TBS  
Caspase-3 substrate (Ac-DEVD-pNA) Dilute the 20 mM stock to 2 mM with 1 x assay 
buffer 
Caspase-3 inhibitor (Ac-DEVD.CHO) Dilute the 2 mM stock solution to 200 µM with 1 
x assay buffer 
Caspase-3 positive control Dilute an aliquot to 5µg/ml in 1 x assay buffer 
containing 1 mg/ml BSA 
Citrate buffer (10 mM)   from 0.1 M C6H8O7 x H2O, 0.1M C6H5O7Na3 x 2 
H2O 
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Coomassie staining solution  10 % acetic acid, 20 % ethanol, R250Coomassie 
in dH2O 
Coomassie de-staining solution 10 % acetic acid, 20 % ethanol in dH2O 
DAB-solution  5 ml dH2O, 2 drops buffer stock solution, 4 drops 
DAB stock solution and 2 drops H2O2-solution 
ECL Analysis System  Reagent 1 (1 ml), reagent 2 (1 ml) 
Ethanol  95 %, 75 % with dH2O 
Flow Cytometry buffer  1 % BSA, 0.1 % NaN3 in PBS 
FBS–RPMI medium 10 % FBS in RPMI 1640 (FBS is inactivated before using by 
56°C in the bath for 30 min).
 
H2O2 peroxid water  3 % in methanol 
HRP-solution (Kit) 5 ml TBS (pH 7.6) + 1 drop. reag. A and 1 drop 
reag. B together  
Lysis buffer (casp.3 activity) 50 mM HEPES pH 7.4, 5 mM CHAPS, 5 mM 
DTT. Dilute 5 x lysis buffer in mq water. 
Lysis buffer (protein isolation; casp-3 act.) 200 mM HEPES pH 7.40, 1 % CHAPS, 50 mM 
DTT, 20 mM EDTA 
Lysis buffer (spleen lymph. isolation) 1.5 M NH4Cl, 10 mM KHCO3, 100 µM EDTA 
PFA solution (FACS)  1 % PFA in PBS 
p-Nitroaniline (casp.3 activity) Dilute the stock solution in 1 x assay buffer and 
determine absorbance at 405 nm using a quartz 
cuvette.  
Pounceau Red (10x)  WB 2 g Ponceau S, 30 g trichloroacetic acid 
     30 g sulfosalicylic acid, dH2O up to 100 ml 
Pounceau Red (1x) WB  with dH2O 
Saponin solution (FACS)  0.1 % saponin in PBS  
SDS-running buffer (WB) 0.025 M Tris pH 8.3, 0.192 M glycerine; 0.1 % 
SDS dH2O to 1L  
TBS, Tris buffered saline solution (IHC) pH 7.4, 100 mM Tris base,0.9 % NaCl 
TBS (WB)     100 mM TRIS pH 7.5, 0.9 % NaCl, dH2O up to 
1L  
5x Transfer buffer (WB)  15.15 g Tris pH 8.3, 72 g glycine, dH2O up to 1L 
1xTransfer buffer (WB) 200 ml 5 x Transfer buffer 20 % methanol (200 
ml) dH2O up to1L 
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Washing solution (WB)  0.1% Tween, 5 % milk powder in PBS 
 
3.4. Laboratory instruments, materials and PC programs. 
LABORATORY INSTRUMENTS 
ABI Prism7700 Sequence Detection System Perkin Elmer Apply Biosystems 
Balance LC 6200 D   Sartorius, Goettingen, Germany 
Bath      Typ SW 20 Julabo GmbH, Seelbach, Germany 
Centrifuge  Rotixa/RP Hettich, Tuttlingen, Germany 
Cryostate  HM 500 OM, Micron GmbH, Walldorf, Germany 
FACS-Calibur   Becton Dickinson, San Jose, USA 
Gloves powder free  Kimberly-Clark Coorporation, Zaventem, Belgium 
Homogenisator Ultra Turrax T8 IKA Labortechnik, Staufen, Germany  
Incubator  Heraeus, Hanau, Germany 
Laminar flow, steril  Heraeus, Hanau, Germany  
Light microscope   Zeiss Axiophot, Jena, Germany 
Mastercycler personal  Eppendorf, Hamburg, Germany 
Miomax MR Imaging film  Kodak, Stuttgart, Germany 
Spectrophotometer   Hewlett Packard, Waldbronn, Germany 
Western blot chambers  BioRad, Munich, Germany  
 
MATERIALS 
1.5 ml Eppendorf tubes Eppendorf, Hamburg, Germany 
15/50 mls Falcon tubes Falcon, Becton Dickinson Labware, Franklin 
Lakes, USA 
Transfer pipetes 3.5 ml  Sarstedt, Nürmbrecht, Germany 
T75 and T25 flasks   BD Pharmingen, Heidelberg, Germany 
100 µm net BD Pharmingen, Heidelberg, Germany  
1000/200/10 µl pipetes BD Pharmingen, Heidelberg, Germany  
slides/cover slides Menzel Glasbearbeitungswerk GmbH, 
Braunschweig, Germany 
PC PROGRAMS 
Cell Quest Program  Becton Dickinson, San Jose, USA 
ImageQuantTL    Amersham  
“Statistical Package for the Social Sciences“ – SPSS -, Version 11.5 
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3.5. Animal care. 
The present study was authorised by the German ministry and carried out 
accordingly to institutional guidelines (LaGetSi, Berlin, Germany Reg.0070/03) as 
well as the Guide for the Care and Use of Agricultural Animals in Agricultural 
Research and Teaching, USA. DBA/2J male and CBA/J female mice were 
purchased from Charles River, Germany, while BALB/c males were obtained from 
BgVV, Germany. The animals were maintained in the barrier animal facility of the 
Biomedical Research Center of Charité, Campus Virchow Klinikum, Medical 
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4. Methods 
 
4.1 CBA/J x DBA/2J murine mating and experimental design 
As proposed by Clark (1980), the combination CBA/J x BALB/c represents the 
normal pregnancy group (0 % abortion, control), whereas the combination CBA/J x 
DBA/2J presents spontaneous miscarriage, with an abortion rate between 15 and 
30 % (Clark 1980; Chaouat 1988; Zenclussen 2002a,b; 2003a; 2005). Two months 
old CBA/J females were paired with 3-4 months old BALB/c or DBA/2J males. In 
every cage, two to three females were placed with one male.  
Several studies proposed increased Th1 cytokine levels in abortion-prone mice 
compared to the CBA/J x BALB/c control combination (Lin et al., 1993; Krishnan et 
al., 1996a, Zenclussen et al., 2003a). In this work we aimed to analyse if apoptosis 
might play a determining role in the onset of miscarriage, therefore the animals 
were divided in the following groups: 
1. group CBA/J x BALB/c  normal pregnancy (control; n = 11) 
2. group CBA/J x DBA/2J abortion-prone combination (n = 14) 
Recent investigations revealed that up-regulation of HO-1 enzyme by cobaltum- 
protoporphyrin (Co-PP; Rosenberg, 1993) application (Zenclussen et al., 2005; 
Sollwedel et al., 2005) or by adenoviral gene transfer (Zenclussen et al. 2006) 
could prevent feti from being rejected, thus improving pregnancy outcome in 
abortion-prone mice. In this work, we investigated whether the protective effect of 
HO-1 in preventing fetal rejection could be associated with its anti-apoptotic 
properties. For testing our hypothesis, HO-1 was up- or down-regulated by 
injecting intraperitoneally (i.p.) abortion-prone mice with a single dose of Co-PP or 
zinc-protoporphyrin (Zn-PP) respectively, on day 4 of pregnancy. The animals 
were grouped as follows: 
1. group CBA/J x BALB/c + PBS i.p. normal pregnancy (control; n = 17) 
2. group CBA/J x DBA/2J + PBS i.p. (n = 10) 
3. group CBA/J x DBA/2J + 5 mg/kg Co-PP i.p. (n = 6) 
4. group CBA/J x DBA/2J + 40 mg/kg Zn-PP i.p. (n = 5) 
The females were checked twice (8:00 AM and 8:00 PM) for vaginal plugs. The 
day, at which the vaginal plug was detected, was considered as day 0 of 
pregnancy. Then, the females were separated from the males. On day 14 of 
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pregnancy, the females were sacrificed by cervical dislocation. We have chosen 
this time point because the placenta is completely formed while the fetus is still 
growing. The uteri were removed and the implantation sites were documented. 
The abortion rate was calculated as number of abortions per total number of 
implantations for every animal. The number of implantations has to be always 
comparable between the groups. In the following pictures the uteri from non-
pregnant (Fig. 8 A), normal pregnant (Fig. 8 B) and abortion-prone DBA/2J-mated 
CBA/J females (Fig. 8 C) are shown. More in detail, Fig. 8 D depicts the different 
development between a fetus from a mouse after 14 days of pregnancy and a 
resorbed fetus from the same time point, which is characterized by its necrotic 
















Fig. 8 Representative pictures showing uteri from non pregnant CBA/J female (A), from CBA/J 
female having a successful pregnancy (B) and from DBA/2J-mated CBA/J female (C) showing 
resorption. In D, 14-day-old fetus (together with its placenta) is compared to a resorption, in which 
fetus and placenta cannot be distinguished. Resorption tissue is characterized by is necrotic and 
hemorrhagic appearance. General view (E) of maternal decidual tissue (a), resorption (b), and 
healthy fetus with its placenta (c). 
 
Resorption samples have been excluded from this study, since proteins and RNA 
isolations were often unsuccessful due to the degree of destruction of the tissue. 
Besides, as can be observed in Fig.9 B, in histology samples some placental cell 
types (i.e. spongiotrophoblast and labyrinthic cells) are missing.  
A C B 
E D 
Normal pregnancy 
CBA/J x BALB/c 
Non pregnant uterus Abortion  
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Fig. 9 General view of healthy placental (A) or resorption (B) tissues. 
 
 
4.2. Sample collection 
On day 14 of pregnancy, CBA/J females previously mated with BALB/C or DBA/2J 
males, were sacrificed by cervical dislocation, placentas were extracted and 
washed in PBS. The samples for RNA or protein isolation were snap frozen in 
liquid nitrogen and kept at – 80 °C until use, whereas those for flow cytometry 
analysis were placed on ice in tubes containing 5 ml RPMI medium. Placentas for 
IHC or TUNEL assay were fixed and kept in 96% alcohol for 24 hs at 4°C. The 
following day the samples were dehydrated in cold ethanol 100% for 1 to 2 hs at 
4°C with 4 changes in total, then put in cold xylol for 1-2 hs at 4°C with 2 changes 
in total. As final step, the samples were immerged in xylol and left at RT for 1-2 hs 
with 1 change in total (Saint Marie, 1962). The placentas were then embedded in 
paraffin at 56 °C for 1-2 hs. The samples were kept at 4 °C until use. Paraffin 
sections from each placental sample were cut at 5 µm thickness using a 
microtome, kept at 37 °C ON and then conserved at RT. Before use, the samples 
were placed on a slide pre-treated with 0.2 % aminosylane. Then, paraffin-
embedded sections were de-waxed as follows: 10 min in 100 %, 95 %, 75 % 
Ethanol , then 5 min in TBS. 
 
4.3. Protein isolation 
Frozen placental and decidual tissues from abortion-prone and normal pregnant 
mice were left in ice to permit thawing and then disaggregated using a glass 
homogenizer in lysis buffer (PBS and 0.1 % Triton-X containing 100 mM 









 - 55 - 
acid as protease inhibitors). After squeezing, the homogenates were collected in 
1.5 ml eppendorf and left on ice. The determination of the total protein 
concentration was performed by Bio-Rad protein Assay Dye Reagent using BSA 
at a standard concentration of 0.1 mg/ml to 1 mg/ml. The protein determination 
was performed in triplicate, after diluting the samples 1:10 in a 96-well plate, and 
then read at 405 nm using a spectrophotometer. The whole procedure was carried 
out at 4 °C. After their quantification, the proteins were aliquoted and kept in –80°C 
until use.  
 
4.4. RNA isolation 
RNA isolation from placenta or decidua tissue was performed by adding 1 ml of 
Trizol to 100 mg of tissue and squeezing using a homogeniser (Ultra Turrax T8). 
The RNA was then extracted with chloroform, precipitated with absolute ethanol, 
washed, and finally resuspended in RNase-free water. The quantification was 
performed by reading ultraviolet absorbance at 260 nm. Then, the samples were 
aliquoted in a concentration of 1 µg/µl, and kept at –80° C until use. 
 
4.5. Ex-vivo isolation of lymphocytes from decidual tissue 
Decidual tissue from normal pregnant or abortion-prone mice was washed in PBS, 
cut into small pieces in 50 ml tubes with 5 ml of Hanks´ Balance solution (HBSS) 
and left on ice until use. Decidual tissue pieces were then filled up with HBSS 
containing 1 mM DTT and incubated for 20 min with occasional shaking at 37 °C in 
the bath. The supernatant containing detached decidual cells was filtered through 
a 100 µm net and placed into a new 50 ml falcon tube on ice. The remaining 
decidual tissue in the tube was filled up with new HBSS but without DTT and again 
incubated for 20 min with occasional shaking at 37 °C in the bath. This procedure 
was repeated twice. On the other hand, the supernatant containing the cells was 
every time collected in the same tube after centrifuging at 1500 rpm, and left on 
ice. Immune cells were then isolated by a Lympholyte-M gradient as indicated by 
the manufacturer and washed with RPMI medium containing 10 % fetal bovine 
serum (FBS). The cells were centrifuged at 1500 rpm at 4 °C for 10 min, and then 
the pellet was re-suspended in 1 ml of RPMI + 10 % FBS and left on ice until used. 
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4.6. Ex-vivo isolation of lymphocytes from spleen tissue 
Spleen cells were isolated in a 6-well plate containing 5 ml of RPMI by crushing 
the organs on a 100 µm net. The total amount of isolated cells (6 ml) were 
collected in a 50 ml Falcon, then 1X lysis buffer was added up to 50 ml and 
incubated for 10 min at RT to permit the erythrocyte lysis. The cells were 
centrifuged at 1500 rpm at 4°C 10 min, then the pellet re-suspended in 15 ml 
RPMI containing 10 % FBS and centrifuged again at 1500 rpm at 4°C for 10 min. 
Finally, splenocytes were re-suspended in 1 ml RPMI + 10% FBS and left on ice 
until used.  
 
4.7. Flow cytometry 
4.7.1. Flow cytometry principle 
Flow cytometers (FC) or fluorescence-activated cell sorting (FACS) machines 
were developed in the 1960s (Van Dilla et al., 1969) as analytical instruments 
offering an advanced technology for rapidly characterizing or separating cells 
based on their physical, biochemical and functional properties within a 
heterogeneous population. Flow cytometry uses the principles of light scattering, 
light excitation, and emission of fluorochrome molecules to generate specific multi-
parameter data from particles and cells at a concentration of 0.5–20 x10 6 cells/ml. 
Measurements include fluorescence from fluorescent probes bound to cellular 
constituent such as DNA or cell-surface antigen as well as intracellular 
components (i.e. proteins like cytokines). The cells are illuminated at a specific 
wavelength from two or more lasers. The cells stained with fluorochromes like 
FITC as Fluorescein-Isothiocyanate, PE as Phycoerythrine or Cy5 as 
Carbocyanine, are measured using an argon laser at a wavelenght (λ) from 488 
nm to 666 nm (FITC λ = 525 nm; PE λ = 578 nm; Cy5 λ = 666 nm). The 
fluorescence intensity is proportional to the amount of antibodies bonded to the 
cells. Forward scatter (FSC) is defined as the measure of the cell size, since the 
greater the scatter, the bigger will be the cell size. The side scatter (SSC) defined 
the intracellular granularity of the cells and its thickness. In the following picture 
(Figs. 10 A and B) are represented the blood cell populations detected (Fig. 10 A) 
and, once localized, gated. Only lymphocyte cells have been considered for the 
analysis. 
 













 The SSC (side scatter) and FSC (forward scatter) signals resulting from blood cells (FSC-
SSC-Dotplot). SSC is referred to as cellular granularity, e.g. granulocyte blood cells with their 
irregularity nuclei have a much more intense SSC than do the more irregular lymphocytes or 
erythrocytes. FSC is related to the size or cell volume signal. It is also determined by other factors 
such as the refractive index of the particles, therefore, a large particle will bend more light than a 
small one. In B the subdivision of the cellular population is associated with its percentage. Modified 
from Stefan Fest´s MD thesis. 
 
 
Cytometers are provided with an electronic circuit, a compensation network that 
measures the intensity of the signal from the signal on the other photodetector. As 
represented in the Figures 11 (A and B), compensation allows correcting for the 
overlap between the fluorescence spectra of different fluorochromes. In our study, 
the compensation was always performed before starting the measurements. 
 
Fig. 11 Compensation (right) allows correcting the fluorescence spectra crossover of different 
fluorochromes (left).  
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4.7.2. Analysis of the data 
The FC data were analysed by using the Cell Quest Program for three 
parameters, such as Cy5-, PE- and FITC-conjugated antibodies against each 
other. After measurement of the negative control, the lower window (gate) on the 
left side was created with at least the 99.9% of the entire unstained cell population. 
The negative control or the isotype control staining is representative of the correct 
staining due to the absence of auto-fluorescence or unspecific bindings of the 
antibodies used. The cell populations are defined by quadrants, which are 
described by location (LL, lower-left represents cells negative for the descriptors 
on both the x- and y-axes; UR, upper-right represents cells dual-positive for the 
descriptors on both the x- and y-axes; UL, upper-left represents cells positive for 
the y-axis descriptor, but negative for the x-axes descriptor; LR, lower-right 
represents cells positive for the x-axis descriptor, but negative for the y-axis 
descriptor). The results are expressed as percentages of cells in specific 
quadrants compared to all cells represented in the plot. 
 
4.7.3. Stimulation of cytokine production and Golgi blockade 
Isolated spleen or decidual lymphocytes was left on ice, each in 1 ml RPMI + 10 % 
FBS, and then re-suspended, transferred into a 6-well plate (1.5 x 106 cells/ml) 
and stimulated using 1 ml RPMI medium and 10% FBS with 50 ng/ml PMA and 1 
µg/ml ionomycin in a humidified incubator at 37°C with 5% CO2. After the first 
hour, 2 µM monensin was added in each well to the medium for blocking the Golgi 
in order to stop the intracellular transport, and the incubation continued for 3 more 
hours.  
 
4.7.4. Staining with extracellular antibodies 
After incubation, the 2 ml cell re-suspension was divided into FACS tubes and 
washed by adding FC buffer. Then, the cells were centrifuged at 1500 rpm for 10 
min at 4°C, the supernatant was removed and the pellet was re-suspended in 100 
µl FC buffer containing the diluted extracellular antibodies (1:100, CD4-FITC- and 
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4.7.5. Fixation 
After incubation, the cells were washed by adding FC buffer, then centrifuged at 
1500 rpm at 4°C for 10 min, the supernatant was removed and the pellet was re-
suspended in 100 µl 1% PFA. The cells were incubated ON at 4°C, to permit the 
cellular fixation.  
 
4.7.6. Permeabilization and intracellular staining 
The following day, cells were washed with FC buffer, then centrifuged at 1500 rpm 
at 4 °C for 10 min, and the supernatant was removed. The pellet was re-
suspended in 100 µl of a solution containing the intracellular antibodies (PE-
labeled anti-TNF-α or anti-IL-10-PE), both diluted 1:200 in 0.1 % saponin. The 
cells were incubated for 20 min at 4°C in darkness. After incubation, the cells were 
washed with 0.1 % saponin, centrifuged at 1500 rpm at 4°C for 10 min. The 
supernatant was removed and the pellet was re-suspended in 100µl in FC buffer 
to be read in a FACS-calibur. Negative controls were performed by using the 
respective isotype controls and unstained cells. Table 2 summarized the schema 
of the staining.  
 
Table 2 Scheme of pipetting for staining decidual 
lymphocytes. One cell tube can be simultaneously 
stained with three fluorochrome-antibodies. For 
every sample, unstained cells representing the 




4.8. Apoptosis detection by annexin-V/Propidium Iodide labeling 
4.8.1. Principle 
An event characterizing early-programmed cell death is the loss of membrane 
phospholipid asymmetry, with the translocation of phosphatidylserine (PS) from 
the inner leaflet of the phospholipid bilayer to the cells surface (Hengarter, 2000). 
Exposure of PS provides a simple means for detecting cells undergoing apoptosis. 
Annexin–V (35 KDa), a member of annexin family of calcium-dependent 
phospholipid binding proteins, has a high affinity for PS-containing phospholipid 
FACS-tubes 1 2 3 
Type of sample Control anti- anti- 
FITC / CD4 CD4 
PE / TNFα  IL-10 
Cy5 / CD8 CD8 
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bilayers (Fig. 12 A and B). Therefore, annexin-V-FITC conjugated represents a 
convenient tool in detecting early apoptosis (Vermes et al., 1995). 
 
Fig. 12 Schematic representation of the Annexin V assay. The picture shows the inversion of 
phosphatidylserine (PS) after induction of apoptosis, and subsequent binding of annexin-V-FITC to 




4.8.2. The assay 
The assay employs a fluorescein-labeled annexin-V (annexin-V-FITC) together 
with propidium iodide (PI). As already described above, during the early stage of 
programmed cell death, the PS are exposed on the cell membrane, and annexin-V 
binds them in a calcium-dependent manner. PI can readily move across the 
plasmatic membrane binding the DNA, therefore staining late apoptotic cells, 
whose membranes are already permeable or dead cells. Therefore, this assay 
allowed the detection of apoptosis as well as the differentiation between early 
apoptotic cells (annexin-V+) and late apoptotic cells (annexin-V+/PI+) from viable 
(annexin-V-/PI-) or necrotic (PI+) cells (Fig. 13).  
 
Fig. 13 Representative dot plots of FITC-
annexin-V/PI two parameter flow cytometry. In 
the picture it is possible to detect and 
distinguish early apoptotic cells (annexin-V+) 
and late apoptotic cells (annexin-V+/PI+) from 
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4.8 3. Experimental procedures 
The ex-vivo early and late apoptotic rates in decidual and spleen lymphocytes 
from normal or abortion-prone mice were analysed by detecting annexin-V-FITC 
conjugated and PI positive cells using flow cytometry. After isolation, spleen and 
decidual cells were collected and placed into tubes, then washed by adding 1 ml of 
cold PBS. The cells were then centrifuged at 1500 rpm at 4 °C for 10 min, the 
supernatant was removed and the pellet re-suspended in 100 µl 1X binding buffer 
containing 2 µl/sample of annexin-V-FITC as well as 2 µl/sample PI. This was 
incubated for 15 min in darkness at RT. After incubation, the cells were washed 
with 1 ml cold PBS, then centrifuged 1500 rpm at 4°C for 10 min and the 
supernatant was removed. The pellet was re-suspended in 100 µl/tube of 1X 
binding buffer and the cells were analysed by flow cytometry within 1 hour. 
Negative controls for each sample were performed by omitting annexin-V-FITC 
conjugated or PI. 
 
4.8.4. Data analysis 
The analysis of the data was performed by using the Cell Quest Program for the 
parameters FITC-annexin-V conjugated and propidium iodide. After the 
measurement of the negative control, the lower window (gate) on the left side was 
created with at least the 99% of the entire unstained cell population. The 
populations of cells are defined by quadrants as already mentioned. 
 
4.9. Apoptosis in placenta: measurement of caspase-3 activity 
4.9.1. Principle and assay 
The effector protein, caspase-3, is the most studied caspase of all mammalian 
caspases. This enzyme can process caspases 2, 6, 7 and 9 and specifically 
cleaves many key proteins, leading to apoptosis induction. In addition caspase-3 
plays a central role in mediating nuclear apoptosis including chromatin 
condensation and DNA fragmentation as well as blebbling (Hengartner, 2000). 
The caspase-3 colorimetric assay is based on the hydrolysis of the peptide 
substrate acetyl-Asp-Asp-Val-Asp p-nitroanilide (Ac-DEVD-pNA) by caspase-3, 
resulting in the release of the p-nitroaniline (pNA) moiety, as depicted in the Fig. 
14 (Sass et al., 2003).  
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Caspase-3 






Fig. 14 Illustrative representation of caspase-3 hydrolysis of AcDEVD-pNA substrate. 
 
P-nitroaniline has a high absorbance at 405 nm. The concentration of the pNA, 
directly proportional to the caspase-3 activity, can be calculated in µmol pNA 
released per min per ml of placental protein homogenate. The formula is: µmol 
pNA x d / t x v, where “v” is the volume of sample in ml, “d” is the dilution factor 
and “t” is the reaction time in minutes. 
 
4.9.2. Experimental procedure 















 2 µM 
Reagent blank -- -- 90 µl -- 10 µl 
Placental homogenates 5 µl -- 85 µl -- 10 µl 
Placental homogenates  
+ inhibitor 
5 µl -- 75 µl 10 µl 10 µl 
Caspase-3 positive control -- 5 µl 85 µl -- 10 µl 
Caspase-3 positive control  
+ inhibitor 
-- 5 µl 75 µl 10 µl 10 µl 
 
Table 3  Reaction schema of pipetting for 96-well plate. 
 
4.9.2.2. Steps of the experiment 
Before starting the experiment, a series of p-nitroaniline solutions at the 
concentration range of 10 to 200 µM (Table 4) have been prepared. 100 µl of each 
dilution was added to a well of the 96-well plate. Assay buffer (100 µl) was 
included as blank. The absorbance was read at 405 nm using a 
spectrophotometer. A calibration curve of the absorbance was carried out by 
plotting the OD405 values versus the concentration of p-nitroaniline per well, in 
mmol, as indicated in Table 4. 
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Table 4 Scheme of p-
nitroaniline standard concentrations, 
prepared by diluting the p-nitroaniline 
stock solution in 1x assay buffer. 
 
 
After isolation, 50 µg of placental homogenates (5 µl) or caspase-3 positive control 
(5 µl) was put in the specific wells, as illustrated in the Table 3. The order of 
addition on the well plate was made as follows: 
 
• 1x assay buffer.  
• caspase-3 inhibitor.  
• caspase-3 substrate. 
 
The reaction started immediately after addition of caspase-3 substrate. The plate 
was gently mixed by shaking while avoiding bubbles, covered and incubated at 
37°C for 90 minutes. When the signal was too low, the incubation continued ON, 
as suggested by the manufacturer. The results were calculated normalizing for the 
p-nitroaniline standard concentrations described in Table 4. 
 
4.10. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end 
labelling (TUNEL) 
4.10.1. Principle 
Extensive DNA fragmentation is a characteristic event of late apoptosis 
(Hengartner, 2000). The assay TdT-mediated dUTP nick end labelling (TUNEL) 
represents a fast and very sensitive method to detect the cleavage of nuclear DNA 
into nucleosome-sized fragments (approximately 180 bp unit size) using an 
enzymatic labelling of the 3´-OH terminal with modified nucleotides (X-dUTP, X= 
fluorescein; Fig. 15). During the reaction, the enzyme terminal deoxynucleotidyl 
transferase (TdT) catalyses polymerisation of fluorescein labelled nucleotides to 
free 3´-OH DNA ends of double-stranded DNA breaks independent of a template. 
Incorporated fluorescein is then conjugated with anti-fluorescein antibody 
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conjugated with horse-radish-peroxidase (POD). After reaction, stained cells can 




Fig. 15 Schematic illustration of TdT-mediated dUTP nick end labelling (TUNEL) method. 
 
 
4.10.2. Steps of the experiment 
The detection of apoptotic cell death at single cell level was performed using the In 
Situ Cell Death Detection Kit, POD. The sections were treated with 10 mM citrate 
buffer pH 6 for 5 min at 600 W in microwave to unmask possible unspecific binding 
in the tissue, then refilled with TBS. The samples were then washed in TBS twice 
(5 min each). 25 µl/section of TdT enzyme + nucleotides mix were added and 
incubated for 60 min in a humidified chamber, modifying the incubation 
temperature from the original protocol (RT instead of 37 °C). The samples were 
then washed in TBS twice (5 min each), and the endogenous peroxidases were 
blocked by adding 3 % H2O2 on methanol for 30 min. After washing, the samples 
were incubated in POD (25 µl/sample) for 30 min at RT, and washed again. The 
sections were developed with 3-amino-9-ethylcarbazole (AEC) + substrate-
chromogen, counterstained with haemalum for 2 min and mounted in Aquatex. 
Negative controls were performed by replacing the TdT enzyme with the label 
solution.  
 
4.10.3. Data analysis 
The number of TUNEL+ cells/mm2 of placental tissue was evaluated using a light 
microscope with a scaled-eye piece, pre-calibrated with a slide micrometer using a 
magnification of 200 X (20 X objective and 10 X ocular). The counting was 
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4.11. Cellular localization of pro- and anti-apoptotic molecules at the fetal--
maternal interface 
4.11.1. Principle 
The term “immunohistochemistry” (abbr. IHC) refers to techniques applicable to 
light as well as fluorescence microscopy, using antibodies (Abs) specific for 
identifying antigens located in normal or pathologic tissues. The IHC method we 
used, is called “Labelled (Strept)Avidin-Biotin Method”(LSAB), since the basic 
reaction is based on the strong affinity (Km= 10-15 M) of the glycoprotein 
streptavidin/avidin for biotin (Gonzalez et al., 1999). Biotin is easily conjugated to 
antibodies and enzyme markers. In the system used in the context of this work, 
after binding of the antigen with the first antibody, this complex recognizes and 
binds the biotinylated-secondary antibody (bridge antibody, Fig. 16). Then, the 
secondary biotinylated antibody, through biotin, recognizes the biotin-binding 
hydrophobic pockets in avidin or streptavidin already labeled with peroxidases 
(Horse radish-peroxidase, HRP, solution). The use of chromogens (e.g. 3,3-
Diamino benzidine, DAB, or 3-Amino-9-Ethylcarbazol, AEC, complex) permits the 
staining pattern to be visualized through the specific color (brown or red). Non-
specific background staining is avoided by blocking endogenous peroxidase via 
pre-incubation of the sections in absolute methanol containing hydrogen peroxide. 
Polyclonal antibodies usually contain antibodies specific for several antigenic 
determinants on the antigen resulting in “false positives” (Bancroft and Gamble, 
2002). Therefore, the negative control, performed without the primary antibody by 
adding only BSA or serum, represents an essential test for the non-specificity of 
the secondary antibody. Moreover, in order to exclude the possibility of the primary 
antibody having unspecific bindings, thus creating “false positives”, the primary Ab 
could be incubated with its blocking peptide, a synthetic molecule that mimics the 
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tissue (mouse) 
antigen ( from mouse tissue) 
I  antibody (rabbit / goat anti mouse) 























4.11.2. Steps of the experiments. 
After de-waxing, in order to block the endogenous peroxidase activity, the sections 
were treated with 3 % hydrogen peroxide in methanol (50 µl/ section) for 20 min at 
RT in a humidified chamber. Then, the tissues were again washed twice in TBS 
and blocked with 5 % BSA in TBS (50 µl/ section) for 20 min at RT in a humidified 
chamber. The samples were incubated ON at 4 °C with the primary antibody (the 
dilutions used are described in Table 5) in 5 % BSA in TBS (30 µl/ section) in a 
humidified chamber. On the following day, after washing twice in TBS, the 
samples were stained with the secondary biotinylated antibody diluted in 5 % BSA 
for 1h at RT (50 µl/section). Then 1 drop/section of HRP-conjugated solution was 
added and incubated for 30 min at RT in a humidified chamber after washing twice 
in TBS. Finally, the sections were developed with DAB (50 µl/section), incubating 
for 7 min RT and then washed twice in TBS. To counterstain, the sections were 
incubated with haemalum (50 µl/section) for 2 min at RT and then washed in tap 
water until a limpid solution was obtained. Then, the sections were quickly washed 
sequentially in alcohol 75 %, 95 %, 100 % and left 2 x 5 min in xylol. The cover 
slide was mounted using Roti Histo-kit. Samples treated with AEC+substrate-
chromogen (1 drop/section, instead of DAB), were washed twice in TBS, 
counterstained with Hemalaun, washed in tap water and immediately mounted 
with Aquatex mounting media. Negative controls were performed by replacing the 
primary antibody with 5 % BSA in TBS or by incubating the antibodies previously 
with a commercial blocking peptide for two hours. 















4.11.3. Light microscope analysis. 
The pattern and intensity of staining in the different cell types of placenta and 
decidual samples was evaluated by two independent observers using a light 
microscope at a magnification of 200 x (20 x objective and 10 x ocular). The 
degree of staining in each placental cell type, as well as in decidua, was graduated 
semi-quantitatively as: negative (-), weak (+), moderate (++), high (+++) or intense 
(++++), and these marks were later converted into numerical scores (0, 1, 2, 3 and 
4, respectively) for a semi-quantitative analysis as previously described 
(Zenclussen et al., 2003 a). 
 
 
4.12. SDS Page and Western Blot (WB) 
4.12.1. Principle 
Western blotting assay detects the protein amount in cells as well as in tissue 
extracts. First, the proteins are separated by their size using a SDS-
polyacrylamide gel electrophoresis (known also as SDS-PAGE electrophoresis). 
The sodium duodecylsulphate sulfate (SDS), a reductor reagent, completely 
denatures the proteins by breaking their covalent bindings responsible for the 
tertiary or quaternary structure. When the proteins are separated on the gel, they 
can be transferred in a nitrocellulose membrane and then labelled by incubating 
with a labelled antibody or by using a primary antibody followed by a secondary 
enzyme-conjugated antibody. The bands can be visualized e.g. on X-ray film, and 
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Tiff images or gel files by comparing the relative darkness, or intensity, of different 
bands on the scanned image, evaluating the relative density of bands. Considering 
that the computer image is composed of individual pixels, each pixel represents a 
numerical value corresponding to the optical density of the gel at that point. 
 
4.12.2. Experimental procedure and analysis 
10 µg of placental proteins were separated in a 10 % sodium duodecylsulphate 
(SDS)-polyacrylamide gel electrophoresis at 100 V for 1 to 2 hours at RT and then 
transferred to a nitrocellulose membrane for immunoblotting ON at 10 V. 
Membranes were blocked for two hours at RT in a 5% milk solution/TBS and 
thereafter incubated ON at 4 °C with antibodies against Bcl-xS, caspase-3, Bag-1, 
Bcl-2 diluted 1:200 in 5 % milk/TBS. After washing twice with 0.5 % Tween and 5 
% milk in TBS, a secondary biotinylated antibody HRP-conjugated diluted 1:5000 
in 5 % milk/TBS was added to the system for 1 h at RT. Bands were revealed by 
chemiluminescence using a commercial kit under exposure onto Miomax MR 
Imaging film. As loading control, we used a β−actin antibody in a dilution 1:1000. 
Positive bands were quantified using ImageQuant TL program from Amersham. 
Data are expressed as X/β-actin, X being the analysed protein. 
 
4.13. Real time RT-polymerase chain reaction (PCR) 
4.13.1. Traditional PCR versus Real Time RT-PCR 
A powerful technique for directly amplifying short segments of the genome is 
provided by the polymerase chain reaction (PCR). PCR assay allows the 
amplification of a region between two defined sites. The steps to perform one PCR 
cycle are summarized in Fig. 17. Briefly, double stranded DNA is denatured, and 
the single strand is annealed with two short primer sequences (~ 20 bases each 
for real time PCR and bigger for traditional PCR), which are complementary to the 
sites on the opposite strands on either side of the target region. The DNA 
polymerase enzyme is used to synthesize a single strand from the 3´-OH end of 
each primer. The entire cycle can then be repeated by denaturing the preparation 
and starting again. The number of copies of the target sequence grows 
exponentially until reaching a plateau at which more template accumulates than 
the enzyme can extend; then the increase in target DNA becomes linear. The 
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traditional PCR method uses agarose gel for detection of PCR amplification at the 
final phase or end point of the PCR reaction. There are several disadvantages 
related to analysis at the end point, like low resolution, the fact that the results are 
not expressed as numbers, poor precision and low sensitivity. Moreover, at that 




Fig. 17         Representation of PCR method. 
 
 
4.13.2. Principle of Real Time RT-PCR 
Real Time PCR is a very sensitive and accurate assay, which represents a novel 
technique for measuring the ”real time” accumulation of products during the 
exponential phase of the PCR reaction using a dual-labeled fluorogenic probe. 
This probe is an oligonucleotide, dually labeled with a reporter dye (e.g. FAM, 6-
carboxyfluorescein) covalently attached to the 5´end and to a quencher dye (e.g. 
TAMRA, 6-carboxytetramethylrhodamine) covalently attached to the 3´end. The 
proximally located quencher dye absorbs the emission of the reporter dye as long 
as the probe is intact. During the extension phase of the PCR reaction, the 
hybridized probe is hydrolyzed by 5´-nuclease activity of the Taq-polymerase, 
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fluorescence emission of the reporter dye, which is proportional to the initial 
amount of template (Overberg et al. 1999). Real time RT-PCR detects PCR 
amplification products using a start material cDNA in an earlier phase of the 
reaction, when there is the 100 % of reaction efficiency. A schematic 
representation of the real time-RT-PCR principle and the graphic analysis are 










 Schematic representation of the real time-PCR principle (A and B) and graphic analysis 
(C). Upon amplification of the target gene, the probe is displaced and subsequently hydrolyzed by 
the Taq DNA polymerase. The probe is formed by a reporter (R) and a quencher (Q), which are 
attached to the 5’ and 3’ ends to the target gene. The quencher absorbs the fluorescence of the 
reporter fluorochrome as long as the probe is intact. The Taq polymerase enzyme separates the 
reporter from the quencher fluorochrome so that the fluorescence of the reporter fluorochrome 
becomes detectable at 488nm. (A, B from Mocellin et al., Trends Mol Med 2003). During each 
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accumulation of free reporter fluorochromes. The cycle at which the fluorescence reaches a 
threshold value is called threshold cycle (CT value) which is inversely proportional to the starting 
amount of the target DNA. Real-time PCR monitors the fluorescence emitted during the reaction as 
an indicator of amplicon production at each PCR cycle, in real time ( Threshold value is the level of 
detection or the point at which a reaction reaches a fluorescent intensity above background. 
 
 
4.13.3. cDNA synthesis 
For cDNA synthesis, samples containing 2 µg of total RNA were placed for 2 min 
on ice and 2.5 mM dNTPs, 2 U/ml DNAse I and 40 U/ml RNA-se inhibitor were 
mixed and added in a reaction buffer. After incubation for 30 min at 37 °C, the mix 
was heated to 75 °C for 5 min. 200 U/ml reverse transcriptase and RNA-se 
inhibitor were prepared in RNA-se free water and incubated at 42 °C for 60 min 
followed by incubation at 94 °C for 5 min. The samples were left at –20 °C until 
used. 
 
4.13.4. Experimental procedure 
Amplification reactions consisted of 1 µl of cDNA (for Bag-1, Bcl-xL, Bcl-2, Bax) or 
2 µl of cDNA (for TNF-α), 6.25 µl Mastermix containing PCR buffer, dNTPs, MgCl2 
and Ampli-Taq DNA polymerase, 3 µl of the primer mix, 0.5µl of the fluorescent 
probes and RNA-se free water until 13 µl. PCR reactions were performed as 
follows: 2 min at 50 °C followed by an initial denaturation step of 10 min at 95 °C, 
followed by 15 s at 95 °C and 1 min at the appropriate annealing temperature 
(usually 60 °C) for 40 cycles. β-actin was used as housekeeping gene. All 
reactions were performed on the ABI Prism 7700 Sequence Detection System. 
Bag-1, Bcl-2, Bax, Bcl-xL and TNF-α were tested in placenta and decidua 
samples.  
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probe (FAM labelled) 
 
TGAACCGGCATCTGCACA  





probe (FAM labelled) 
 
GCTAAC CAC CTG CAAGAATTG AAT 
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The real time RT-PCR results were obtained as exportable computer data. For 
each probe the amplification plot was obtained and analysed in duplicate. “Ct” 
represents the cycle number at which the amplification reaction begins. Each 
sample was normalized to β-actin by calculating the difference between the Ct for 
β-actin and the cT for the molecules studied (anti- and pro-apoptotic molecules), 
as: ∆cT= cT β-actin- cT each molecule. As lower ∆cT means more cDNA, which 
was obtained from mRNA, and considering the exponential increase of cDNA in 
PCR, the mRNA quantity has been calculated using the following formula: mRNA= 
2-∆cT 
 
4.14. Statistical analysis. 
The data were analysed using Microsoft Excel, Version 2002, together with the 
software “Statistical Package for the Social Sciences“ – SPSS -, version 11.5. The 
data are expressed as medians or medians ± 75 % quartiles (graphics include box 
plots) due to their non-parametric distribution and the heterogeneity of the group. 
The box plots include all the data, while showing the distribution of the samples. 










Besides, the total number of samples employed for each experiment is indicated at 
the bottom of each box plot. The differences between abortion-prone and normal 
pregnancy groups were calculated using the non-parametric Mann-Whitney-U test, 
whereas when analyzing more then one sample (e.g. in Co-PP and Zn-PP treated 
animals) the non-parametric Kruskal Wallis test was used. In all cases *p<0.05; 






























5.1 Apoptosis in the abortion-prone murine combination CBA/J x DBA/2J 
as compared to the normal combination CBA/J x BALB/c 
 
5.1.1. DBA/2J-mated CBA/J females showed increased abortion rate as 
compared to BALB/c mated CBA/J 
As previously reported (Clark et al., 1980; Chaouat et al., 1988; Zenclussen et al., 
2003a), CBA/J females previously mated with DBA/2J male showed significantly 
up-regulated abortion rate compared to BALB/c-mated CBA/J females (Fig. 20 A). 
We did not observe differences among both groups concerning the number of 

















  (A) Abortion rates. DBA/2J-mated CBA/J females presented increased abortion rate 
compared to BALB/c-mated CBA/J females on day 14 of pregnancy. (B) Implantation rates. The 
implantation rates were comparable between both groups. The data are shown as median ± 75% 
quartiles and are representative of two different experiments. Statistical significance was evaluated 
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CBA/J x BALB/c 
CBA/J x DBA/2J A B 
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5.1.2. Th1 and Th2 cytokines in abortion versus normal pregnancy 
5.1.2.1. Decidual cells from abortion-prone mice produced significantly more 
TNF-α and less IL-10 when compared to normal pregnant mice 
As already described by several studies an imbalance in the Th1/Th2 cytokine 
ratio could be associated with pregnancy failure (Clark et al., 1999; Lin et al., 
1993; Wegmann et al., 1993; Krishnan et al., 1996; Raghupathy et al., 1997, 
1999). In this study, we analysed by flow cytometry the ability of decidual immune 
cells, isolated from abortion-prone or normal pregnant mice, to produce Th1 or 
Th2 cytokines after PMA/Ionomycin stimulation, which is known to stimulate 
mostly memory cells. This may serve as a mirror of the in vivo cytokine production. 
We observed a statistically significant augmentation in the TNFα/IL-10 ratio (Fig. 
21) in decidual lymphocytes from abortion-prone mice when compared to normal 
pregnant mice on the 14th day of gestation, confirming increased ability of decidual 
cells to produce Th1 cytokines and decreased Th2 cytokine production in abortion-
prone animals.  
 
5.1.2.2. Placental and decidual TNF-α mRNA levels were augmented in 
abortion-prone mice compared to the controls 
 
Fig. 21 TNF-α/IL-10 ratio. The Th1/Th2 cytokine ratio of was significantly up-regulated in decidual 
immune cells from abortion mice compared to normal pregnant mice on the 14th day of pregnancy. 
Data are presented as median ±75% quartiles. Statistical significance was evaluated by the non-
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Real time RT-PCR analysis confirmed a slight increase in TNF-α mRNA levels in 
decidua (Fig. 22 A) as well as in placenta (Fig. 22 B) from the abortion-prone 
group compared to the normal pregnancy. The increase was, however, non-
significant. This may be due to the fact that the mRNA levels were measured in 
the whole tissue, comprising TNF-α from all cells (trophoblasts and immune cells 
in the case of placenta or decidual cells and immune cells in the case of 
















Fig. 22 TNF-α mRNA levels. Slightly elevated TNF-α  mRNA levels were observed in decidual (A) 
and placenta (B) tissues from the abortion group compared to the controls as analysed by real time 
RT-PCR and indicated by 2-∆cT. Data are presented as median ±75% quartiles. Statistical 
significance was evaluated by the non-parametric Mann-Whitney—U-test. Circles mean outliers, 
were included in the statistical analysis. 
 
 
5.1.3. Apoptosis in the murine combination CBA/J x DBA/2J 
5.1.3.1. Spleen or decidual lymphocytes from abortion-prone and normal 
pregnant mice presented similar apoptotic rates 
Considering the up-regulated levels of TNF-α protein we found in the abortion 
combination, and knowing that this pro-inflammatory cytokine is directly involved in 
inducing apoptosis via its receptors (TNF-RI and TNF-RII; Bowen et al., 2000), we 
analysed by flow cytometry cells positive for annexin-V in spleen as well as 
decidual immune cells positive for annexin-V. Annexin-V is known as a marker for 
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early apoptosis, while cells positive for both annexin-V and propidium iodide are 
thought to be late apoptotic cells. Moreover, this assay allowed distinguishing 
apoptotic cells from viable (annexin-V-/PI-) or necrotic (PI+) cells (Fig. 13). Our 
analysis revealed no significant differences in the apoptotic rate between local 
(decidual) or systemic (spleen) lymphocytes from DBA/2J-mated CBA/J females 
compared to BALB/c-mated CBA/J mice, suggesting that apoptosis is not involved 





 Early and late apoptotic rates analysed by annexin-V-FITC and propidium iodide (PI) 
staining using flow cytometry. Data are shown as medians. No significant differences could be 
observed in any of the analysed parameters between the two groups when analysed by the non-
parametric Mann-Whitney-U test. 
 
 
5.1.3.2. No signs of increased local apoptosis in the murine abortion 
combination compared to normal pregnant mice 
The activity of caspase-3, a key enzyme in apoptotic process, was slightly higher 
in the abortion-prone group compared to normal pregnancy group (Fig. 23 A). 
However this difference was not statistically significant. Furthermore, the analysis 
of cellular DNA fragmentation by TUNEL assay confirmed similar apoptotic rates 
between both experimental groups on day 14 of pregnancy (Fig. 23 B). 
Representative pictures of TUNEL staining for both normal and abortion-prone 
mice are shown in Figs. 23 C and D. The negative control staining can be 




Spleen Annexin-V+cells PI+cells Annexin-V/PI+cells Viable 
CBA/J x BALB/c 
n=8 
8.04 6.90 21.57 55.80 
CBA/J x DBA/2J 
n=9 
4.65 11.47 38.58 31.39 
Decidua Annexin-V+cells PI+cells Annexin-V/PI+cells Viable 
CBA/J x BALB/c 
n=6 
26.11 1.40 8.23 59.69 
CBA/J x DBA/2J 
n=5 
20.90 1.57 5.65 65.67 
















 (A) Caspase-3 activity. Slightly, but not significantly augmented levels of caspase-3 activity 
were observed in placenta from abortion compared to normal pregnant mice. (B) TUNEL+ cells. 
Analysis of DNA fragmentation by TUNEL in placental cells revealed a marginal and not statistically 
significant augmentation in the number of TUNEL+ cells in abortion group compared to the controls. 
Data are presented as median ±75% quartiles. Statistical significance was evaluated by the non-
parametric Mann-Whitney-U-test. Asterisks representing extreme values were included in the 
statistical analysis. (C, D, E) Representative pictures of TUNEL nuclear staining. The pictures show 
TUNEL+ cells in normal (C) or abortion (D) samples developed with AEC Substrate Chromogen 
and counterstained with Hemalaun. The negative control (E) was performed by replacing the TdT 
enzyme with the label solution. Pictures were taken using a 20X magnification of the objective lens. 
 
5.1.3.3. Pro- and anti-apoptotic molecules at the feto-maternal interface 
Having found comparable apoptotic activity at the feto-maternal interface from 
normal pregnant mice and mice undergoing immunological abortion, we aimed to 
analyse the expression of pro- and anti-apoptotic molecules. 
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5.1.3.3.1. Cellular localization investigated by immunohistochemistry (IHC): 
increased expression of Bcl-2 at the feto-maternal interface 
The localization of pro- and anti-apoptotic molecules (caspase-3, Bcl-xS and Bag-
1, Bcl-2 respectively) was investigated using IHC. Pro- and anti-apoptotic 
molecules were detected in all placental cell types (giant cells, 
spongiotrophoblasts, and labyrinthic cells) as well as in maternal decidual cells 
from both abortion-prone and control animals. When semi-quantifying the staining 
intensity, a significant increase in the expression of the anti-apoptotic Bcl-2 could 
be observed in decidual cells as well as in spongiotrophoblasts and labyrinthic 
cells of placental samples from the abortion-prone group, when compared to the 
controls (Fig. 24 A-C). No differences could be observed for any of the other 




















 Expression of Bcl-2 in decidual cells (A) spongiotrophoblasts (B) and labyrinthic cells (C). 
Semi-quantitative analysis revealed significantly enhanced expression of Bcl-2 in decidual as well 
as placental cells. Data are presented as median ±75% quartiles. Statistical significance was 
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Bag-1, an anti-apoptotic molecule as well, and the pro-apoptotic molecules, Bcl-xS 
and caspase-3 showed a comparable expression in decidual and placental cells 




 Expression of pro- and anti-apoptotic molecules as analysed by IHC. Data are 
shown as medians. No significant differences could be observed in any of the analysed parameters 
between the two groups as analysed by the non-parametric Mann-Whitney-U test. 
 
 
Representative staining patterns are shown in Figures 25 A-D together with the 
















 Picture representing IHC staining. The pictures show representative staining fields for Bcl-2 
(A), Bag-1 (B), Bcl-xS (C) or caspase-3 (D) in different placental cell types (Dc: decidual cells; Gc: 
giant cells; Spc: spongiotrophoblast cells; Lc: labyrinthic cells) counterstained with haemalam. 
Bag-1 Giant cells Spongiotrophoblast cells Labyrinthic cells Decidual cells 
CBA/J x BALB/c 
n=7 0.50 0.20 0.50 0.50 
CBA/J x DBA/2J 
n=8 0.50 0.50 0.75 0.50 
Bcl-xS 
    
CBA/J x BALB/c 
n=7 3.00 2.00 1.50 3.00 
CBA/J x DBA/2J 
n=8 2.50 2.00 1.75 3.00 
Caspase-3 
    
CBA/J x BALB/c 
n=7 1.50 2.50 0.50 2.00 
CBA/J x DBA/2J 
















 - 81 - 
Pictures were taken using a 20X (B, E) or 40 X (A, C, D) magnification. (E) the negative control, 
performed without primary antibody or with the blocking peptide. 
 
 
Considering that after 14 days of pregnancy we observed a significant up-
regulated expression of Bcl-2 in decidual as well as in placental cells from 
abortion-prone mice compared to the controls, we decided to analyse this anti-
apoptotic molecule in tissues coming from mice sacrificed on the 18th day of 
gestation. At this time point both, fetus and placenta are completely formed. With 
this complementary analysis we aimed to analyze whether the expression of Bcl-2 
was still up-regulated during late pregnancy (day 18 of gestation). It is important to 
remark here that the tissue specimens included in the study were “healthy” 
placentas in close proximity to resorbed fetuses. Increased Bcl-2 levels at both 
time points could indicate a mechanism to avoid death. When semiquantified the 
staining intensity, a significant increase in the expression of Bcl-2 could be 
observed in decidual cells from abortion-prone mice, supporting the data obtained 
with samples from 14th day of pregnancy. This further suggests that the up-
regulation of Bcl-2 in abortion could be involved in the activation of a protective 
mechanism tending to push the correct development of the placental organ and 




 Expression of Bcl-2 in decidual cells of tissues coming from abortion and normal pregnancy 
mice sacrificed at day 18 of gestation. The semi-quantitative analysis revealed significant 
expression of Bcl-2 in decidual cells from abortion compared to the control. Data are presented as 
median ±75% quartiles Statistical significance was evaluated using the non-parametric Mann-
CBA/J x BALB/c 
CBA/J x DBA/2J day 18 of pregnancy 
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5.1 3.3.2. Pro- and anti-apoptotic protein expression: up-regulation of Bcl-2 in 
CBA/J x DBA/2J mice compared to the controls 
We quantified the expression of pro- and anti-apoptotic proteins (Bcl-xS, Bcl-2 and 
Bag-1) in whole placental extracts from mice sacrificed after 14 days of pregnancy 
using Western Blot assay. Positive bands for all molecules were detected in both, 
normal pregnant and abortion-prone mice. Quantification of the band intensities by 
ImageQuant TL software from Amersham (www.Amersham.com) allowed us to 
confirm statistically increased Bcl-2 levels in placental tissues from abortion-prone 




Fig. 27 Quantification of Bcl-2 expression. The intensity of the bands for Bcl-2 in placental 
homogenates from normal pregnant and abortion-prone mice was analysed densitometrically 
referred to β-actin band intensity using the ImageQuant TL software (Amersham). We observed a 
significant up-regulation of Bcl-2 in the abortion-prone group compared to the control. Data are 
presented as median ± 75% quartiles. Statistical significance was evaluated by the non-parametric 




























CBA/J x BALB/c 
CBA/J x DBA/2J 
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In accordance with the previously discussed IHC data, no changes could be 
observed for Bag-1 or Bcl-xS protein expression by Western Blot either (Table 9). 
 
Anti-apoptotic protein CBA/J x BALB/c 
n=4 
CBA/J x DBA/2J 
n=6 
Bag-1 2.15 1.81 
Pro-apoptotic protein CBA/J x BALB/c 
n=4 
CBA/J x DBA/2J 
n=6 
Bclx-S 1.43 1.6 
 
Table 9 Pro- and anti-apoptotic protein expression analysed by Western Blot and quantified 
densitometrically referred to β-actin. No significant difference could be observed in any of the 
analysed parameters between the two groups as analysed by the non-parametric test Mann-
Whitney-U test. Data are presented as median. 
 
5.1. 3.3.3. mRNA levels of pro- and anti-apoptotic molecules by real time-RT-
PCR 
The mRNA levels of Bax (pro-apoptotic), Bcl-2, Bcl-xL and Bag-1 (anti-apoptotic) 
were analysed in placental and decidual samples from both experimental groups 
by using real time RT-PCR. Bcl-2 mRNA levels were slightly augmented in 
abortion-prone animals as compared to normal pregnant individuals. However, no 
statistically significant differences could be observed between normal pregnant 
and abortion-prone mice for Bcl-2 in placental samples (Fig. 28). Bcl-xL and Bax 
mRNA placental expression was also comparable in both groups (Table 10).  
 
 
Fig. 28 Bcl-2 m-RNA levels in decidual tissue. The m-RNA levels for Bcl-2 were analysed in 
placenta using real time RT-PCR and indicated by 2-∆cT. Bcl-2 was slightly but not statistically 
significantly up-regulated in decidua from abortion-prone group compared to the control. Data are 
presented as median ± 75% quartiles in box blot due to their non-Gaussian distribution. Circles 






















CBA/J x BALB/c 
CBA/J x DBA/2J 
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representing outliers were included in the statistical analysis. Statistical significance was evaluated 
by the non-parametric Mann-Whitney-U test. 
 
In decidual samples, the mRNA levels for Bcl-2 were again up-regulated in 
abortion-prone mice as compared to normal pregnant mice, supporting IHC and 
WB data. These augmented levels did not reach significance levels. No changes 
could be observed for Bag-1, Bcl-xL or Bax in decidual tissue (Table 10).  
 
Anti-apoptotic protein Placenta Decidua. 
CBA/J x BALB/c, n=6 0.1127 0.4491 Bag-1 CBA/J x DBA/2J, n=9 0.3301 0.5724 
CBA/J x BALB/c, n=6 0.0219 0.0146 Bcl-xL 
CBA/J x DBA/2J, n=8  0.0396* 0.0178 
Pro-apoptotic protein Placenta Decidua. 
CBA/J x BALB/c, n=5 0.0341 0.0206 Bax 
CBA/J x DBA/2J, n=8 0.0303 0.0183 
 
Table 10 m-RNA levels of pro- and anti-apoptotic molecules in placenta and decidua. Data 
are expressed as 2-∆cT and shown as medians. *: p<0.05 as analysed by the non-parametric test 
Mann-Whitney-U test. 
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5.2. Heme oxygenase 
 
5.2.1. Abortion rates after up- or down-regulation of HO-1 by means of Co-PP and 
Zn-PP 
We analysed the abortion (Fig. 29 A) as well as the implantation rate (Fig. 29 B) of 
mice previously treated with Co-PP or Zn-PP during the implantation window (i.e. 
day 4th of pregnancy). This treatment allowed us to up- or down-regulate the 
protective enzyme HO-1, thus analysing the effect of augmented or diminished 
HO-1 levels on pregnancy outcome. As expected, the abortion rate of DBA/2J-
mated CBA/J females treated with PBS was significantly higher than the PBS-
treated normal pregnancy control mice (Fig. 29 A). Co-PP treatment was effective 
in diminishing the abortion rate, thus preventing fetal rejection, whereas Zn-PP 
treatment significantly boosted the abortion rate. These data strongly suggest that 
the absence or down-regulation of HO-1 negatively influences the pregnancy 
outcome, while its up-regulation has a positive effect. The experiments presented 

















  (A) Abortion rate. DBA/2J-mated CBA/J females presented increased abortion rate 
compared to BALB/c-mated CBA/J females on day 14 of pregnancy. Co-PP application significantly 
diminished the abortion rate, while Zn-PP treatment boosted fetal rejection. (B) Implantation rate. 
The implantation rate was comparable between the two groups. Data are presented as median 
±75% quartiles in box blot due to their non-Gaussian distribution. Statistical significance was 
evaluated by the non-parametric Kruskall-Wallis test followed by the Mann-Whitney-U test between 
CBA/J x DBA/2J + Zn-PP treatment 
CBA/J x BALB/c + PBS 
CBA/J x DBA/2J + PBS 
CBA/J x DBA/2J + Co-PP treatment 
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two particular groups. *: p<0.05; **: p<0.01; ***: p<0.001. Circles and asterisks representing outliers 
and extreme values were included in the statistical analysis. 
 
5.2.2. Anti-apoptotic properties of heme oxygenase during pregnancy 
5.2.2.1. Heme oxygenase down-regulates apoptosis in CBA/J females treated with 
Co-PP 
Heme oxygenase-1 was shown to have anti-apoptotic and tissue-protective 
properties (Wagener et al., 2003; Song et al., 2003; Sollwedel et al., 2005). 
Considering these facts, we up- and down-regulated HO-1 by Co-PP and Zn-PP 
applications, then we analysed the activity of caspase-3 enzyme and the DNA 
fragmentation by TUNEL in those samples from animals treated with Co-PP or Zn-
PP. Interestingly, we observed a slight diminution of the caspase-3 activity in 
abortion-prone mice treated with Co-PP as compared to abortion-prone mice 
treated with PBS (Fig. 30 A). Moreover, the analysis of apoptotic cells by TUNEL 
(Fig. 30 B) further confirmed that apoptosis is tendentially down-regulated in Co-
PP-treated animals as compared to the controls. These data point to a tissue 
protective effect of HO-1 by diminishing the incidence of apoptosis at the feto-
maternal interface, similarly to the data reported for other tissues (Wagener et al., 
















 (A) Caspase-3 activity. Slightly, but not significantly diminished levels of caspase-3 activity 
were observed in placenta from Co-PP-treated mice compared to the controls. (B) TUNEL+ cells. 
Analysis of DNA fragmentation by TUNEL in placental cells revealed a marginal and not statistically 
significant dimininution in the number of TUNEL+ cells in Co-PP group compared to the controls. 









































CBA/J x BALB/c + PBS 
CBA/J x DBA/2J + PBS 
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parametric Mann-Whitney-U test after the Kruskall-Wallis test. Asterisks representing extreme 
values were included in the statistical analysis. 
 
5.2.2.2. Bag-1 expression is up-regulated after HO-1 augmentation by Co-PP 
treatment 
 
In order to investigate if HO-1 augmentation could prevent abortion by diminishing 
apoptosis, we further investigated the levels of apoptosis-related molecules such 
as Bag-1, Bcl-2 and Bcl-xL. Interestingly, Bag-1 protein expression (Fig. 31 A) and 
mRNA levels (Fig. 31 B) were significantly up-regulated in placental homogenates 
after treatment with Co-PP as compared to the PBS-treated control groups or Zn-
PP treated abortion-prone animals. Our data suggest that Bag-1 induction after 

















Fig. 31 Quantification of protein expression (A) and mRNA levels (B) of Bag-1 in placental 
homogenates. In A, the intensity of the bands for Bag-1 was analysed densitometrically referred to 
β-actin using ImageQuant TL software (Amersham). We observed a significant up-regulation of 
Bag-1 protein expression in the group receiving Co-PP compared to the abortion-prone or Zn-PP 
group. In B, a similar tendency could be observed at mRNA levels for Bag-1 in placental tissue. 
Data are presented as median ± 75% quartiles. Statistical significance was evaluated by the non-
parametric Mann-Whitney-U test. *: p<0.05. Circles and asterisks representing outliers and 
extreme values were included in the statistical analysis. 
 
CBA/J x BALB/c + PBS 
CBA/J x DBA/2J + PBS 











































n=3 n=5 n=5 n=4 
p<0,063 
BA
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Immunohistochemistry analysis supported up-regulation of anti-apoptotic 
molecules (i.e. Bcl-2 and Bag-1) in placental cells as well as in deciduas of treated 
samples compared to the controls. On the other hand, pro-apoptotic molecules 




Table 11 Expression of pro- and anti-apoptotic molecules analysed by IHC. Data are shown as 
medians. No significant differences could be observed in any of the analysed parameters between 
the two groups as analysed by the non-parametric test Kruscal Wallis and Mann-Whitney–U tests. 
 
Bcl-2 Giant cells Spongiotrophoblast cells Labyrinthic cells Decidual cells 
CBA/J x BALB/c 
n=7 0.50 0.20 0.50 0.50 
CBA/J x DBA/2J 
n=8 0.50 0.50 0.75 0.50 
CBA x DBA/J + 
Co-PP 
n =7  
3 ** 4 ** 3.7 ** 3.5 * 
CBA x DBA/J + 
Zn-PP 
n =7 
3.2 3.6 3.5 3.7 ** 
Bag-1 Giant cells Spongiotrophoblast cells Labyrinthic cells Decidual cells 
CBA/J x BALB/c 
n=7 0.50 0.20 0.50 0.50 
CBA/J x DBA/2J 
n=8 0.50 0.50 0.75 0.50 
CBA x DBA/J + 
Co-PP 
n =7  
0.6 1 2.2 * 0.75 
CBA x DBA/J + 
Zn-PP 
n =7 
0.5 0.9 1.1 1.5 * 
Bcl-xS Giant cells Spongiotrophoblast cells Labyrinthic cells Decidual cells 
CBA/J x BALB/c 
n=7 3.00 2.00 1.50 3.00 
CBA/J x DBA/2J 
n=8 2.50 2.00 1.75 3.00 
CBA x DBA/J + 
Co-PP 
n =7  
3 4 3.7 3.5 
CBA x DBA/J + 
Zn-PP 
n = 7 
3.2 3.6 3.5 3.7 
Caspase-3 Giant cells Spongiotrophoblast cells Labyrinthic cells Decidual cells 
CBA/J x BALB/c 
n=7 1.50 2.50 0.50 2.00 
CBA/J x DBA/2J 
n=8 1.62 2.00 0.62 2.50 
CBA x DBA/J + 
Co-PP 
n = 7 
3 4 3.7 3.5 
CBA x DBA/J + 
Zn-PP 
n =7 
3.3 3.6 3.5 3.7 
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6. Discussion 
 
The mechanisms leading to successful pregnancy are still poorly understood. 
Novel pathways are being studied in pregnancy-related research.  
 
In the past, several theories were proposed to explain why the fetus is not rejected 
from its mother, despite its paternal inheritance. The explanation provided by one 
of these hypotheses, the “Th1/Th2/Th3 paradigm”, is that augmented Th2/3 
cytokines synthesis accompanied by diminished Th1-cytokines production could 
be involved in avoiding immunological rejection of the fetus (Wegmann et al., 
1993; Clark et al., 1999; Raghupathy et al., 1997, 1999; Lin et al., 2003). This 
hypothesis has triggered a heated debate, since several studies suggest this to be 
an over-simplification (Svensson et al., 2001; Zenclussen et al., 2002a; Chaouat et 
al., 2003).  
The murine combination CBA/J x DBA/2J represents a well-known experimental 
model of Th1-induced abortion, with increased local TNF-α levels at the feto-
maternal interface (Tangri and Raghupathy, 1993; Clark et al., 1999; Raghupathy, 
2001). TNF-α is also known as potent inductor of apoptosis (Baud and Karin, 
2001; Gupta, 2002). It has become clear that apoptosis plays a role in many 
aspects of reproduction like implantation (Hardy, 1999), placental growth and 
development (Joswig et al., 2003). Pregnancy loss and the occurrence of inborn 
structural anomalies are often preceeded by excessive apoptosis in targeted 
embryonic and extra-embryonic tissues (Toder et al., 2002). Considering these 
facts, we therefore aimed to investigate the incidence of cell death in this model in 
order to understand if miscarriage was preceded by augmented apoptotic rates. 
We analysed several key features of apoptosis such as the caspase-3 activity and 
the DNA fragmentation together with pro- and anti-apoptotic molecules, in order to 
establish their role at the feto-maternal interface, by employing 
immunohistochemistry, flow cytometry western blot and molecular biology 
methods.  
Despite augmented levels of Th1 cytokines at the feto-maternal interface, 
apoptosis seems not to play a big role in the onset of abortion. Moreover, our data 
suggest the up-regulation of Bcl-2 as a possible mechanism to keep safe the 
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development of placentas closed to resorbed sites, in order to maintain the correct 
physiology and function of this organ to ensure the fetal growth until birth. 
 
During gestation, heme oxygenase enzyme–1 (HO-1) seems to be protective. As a 
matter of fact, data from our laboratory suggest that HO-1 if up-regulated by Co-
PP injection could prevent abortion, whereas when down-regulated (by employing 
Zn-PP), enhance miscarriage. In this work we investigated the possible 
mechanisms leading to successful pregnancy induced by up-regulation of HO-1. 
Considering the anti-apoptotic properties of HO-1 (at least in vitro), we checked if 
the protective effects of HO-1 during gestation could be due to changes in the 
apoptotic rate and in the expression of apoptotic-related molecules. 
This study strongly supports a very important role for the enzyme heme 
oxygenase-1 in protecting the fetus from maternal rejection, suggesting up-
regulation of Bag-1 by HO-1 as the probable tissue protective mechanism to 
ensure successful pregnancy. 
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6.1. Do the decidual lymphocytes coming from the CBA/J x DBA/2J murine 
combination produce more TNF-α (pro-inflammatory) and less IL-10 (anti-
inflammatory) at the feto-maternal interface as compared to normal pregnant 
mice? 
In recent years, it was hypothesized that cytokines play a determining role in 
pregnancy outcome. The “Th1/Th2/Th3 paradigm” proposes that the ratio of pro- 
(Th1) and anti- (Th2/Th3) inflammatory cytokines could be critical during gestation 
(Wegmann et al., 1993; Chaouat et al., 1995, 2003; Clark et al., 1999). In this 
context, Th2 or Th3 cytokines such as IL-4, IL-10 or TGF-β, would favor the 
maintenance of pregnancy, whereas excessive pro-inflammatory cytokine (i.e. 
TNF-α or IFN-γ) production would be involved in determining fetal rejection 
(Raghupathy, 1997, 1999; Clark et al., 1999; Chaouat et al., 2003; Zenclussen et 
al., 2003a; Lin et al., 2003). Accordingly, administration of IL-10 prevents naturally 
occurring fetal loss in CBA/J x DBA/2J combination (Chaouat et al., 1995); 
successful human pregnancy is totally correlated with the presence of anti-
inflammatory cytokines (i.e. IL-4 and IL-10; Dealtry et al., 2000) and the in vivo 
blocking of the trafficking of Th1 lymphocytes migration to the feto-maternal 
interface by administration of mAbs against selectins improved pregnancy 
outcome in CBA/J x DBA/2J combination compared to the controls (Zambon 
Bertoja et al., 2005). However, recent works questioned the importance of 
Th1/Th2 theory as IL-4 and IL–10 KO mice have normal pregnancies (Svensson et 
al., 2001), pro-inflammatory cytokines are essential to placenta immunity (Barber 
E.M. et al., 2005), and immune cells from patients suffering from spontaneous 
abortion produce less IL-12 than cells from normal pregnant patients (Zenclussen 
et al., 2002a). 
 
In this work, we employed a murine combination representing a well-established 
murine model of abortion, as described by Clark (1980), where CBA/J (H-2k) 
female mice spontaneously show high abortion rates (about 20-40%) when mated 
with DBA/2J (H-2d) males and low abortion rates (usually 0 %) when mated with 
other H2d-bearing males like BALB/c. Several studies carried out employing this 
combination showed augmented pro-inflammatory cytokine production by decidual 
lymphocytes or placental cells from the abortion-prone-CBA/J females, compared 
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to the normal pregnant controls (CBA/J x BALB/c; Chaouat et al., 1995; Clark et 
al., 1999; Zenclussen et al. 2003a, 2005; Zenclussen M.L. et al., 2005). In our 
study, we analysed the ability of decidual lymphocytes to produce Th1 and Th2 
cytokines, respectively TNF-α and IL-10, after PMA and Ionomycin stimulation, 
known to stimulate mostly memory cells as a mirror of the in vivo cytokine 
production. We confirmed increased ability of decidual cells to produce TNF-α 
along with decreased production of IL-10 in abortion-prone animals when 
compared to normal pregnant mice. Considering that trophoblast cells are also 
responsible for synthesis of cytokines, we further analysed total TNF-α mRNA 
levels in both decidua and placenta of abortion-prone animals as compared to 
normal pregnancy group. This augmentation was however only tendentially but not 
statistically significant. Our data confirm the Th1/Th2/Th3 paradigm at least for 
these two clue cytokines, TNF-α and IL-10, while showing that immune cells 
produce TNF-α when a rejection is taking or has taken place. Moreover, these 
results confirmed once more, that abortion events are accompanied by imbalances 
between Th1 and Th2 even when Th2 cytokines are not essential for pregnancy 
outcome or augmented Th1 cytokines can be seen in normal pregnancies. 
Considering the important role of pro-inflammatory cytokines (i.e. TNF-α) in the 
onset of miscarriage in this model, and the ability of TNF-α in triggering apoptosis 
in several other models (Sidoti-de-Fraisse et al., 1998), we aimed to investigate 
whether apoptosis is up-regulated in animals undergoing abortion after observing 
augmented Th1 levels at the feto-maternal interface.  
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6.2. Is the apoptosis of immune cells modified after occurrence of 
immunological abortion? 
Programmed cell death is essential for the development and maintenance of 
cellular homeostasis of the immune system in mammals, because it avoids 
aberrations such as immunodeficiency, autoimmunity and cancer (Vaux and 
Korsmeyer, 1999). We were interested in studying the ex-vivo apoptotic rate (early 
and late) of spleen and decidual lymphocytes immune cells, in order to investigate 
whether apoptotic process could be altered after resorption time (day 8 of 
gestation), i.e. at the day 14th of pregnancy. The data revealed a similar apoptotic 
rate in decidual or spleen lymphocytes from abortion-prone mice compared to 
normal pregnant mice, suggesting that apoptosis of immune cells is not being 
modified after occurrence of immunological abortion. For a long time, apoptotic 
cells were considered to be neutral in immune response. Interestingly, recent 
studies demonstrated that apoptotic cells actively regulate the immune response 
(Voll et al., 1997; Fadok et al., 1998; Byrne and Reen, 2002). Thus, the presence 
of apoptotic cells during monocyte activation increases the secretion of IL-10 and 
decreases the release of TNF-α and IL-12, clearly modifying the Th1/Th2 ratio. 
Moreover, apoptotic cells release TGF-β1, a potent immunosuppressor, which 
contributes to the local suppression of immune response (Chen et al., 2001), and 
after being ingested by macrophages, they can actively alter the biological 
behavior of macrophages, acquiring immunosuppressive properties (Zhang and 
Zheng, 2005). Interestingly, necrotic tumor cells help macrophages to kill tumor 
cells, but apoptotic cells decrease the competence of macrophages in clearance 
tumor cells, promoting their growth (Reiter and Krammer, 1999). Taking these 
facts into consideration, we can hypothesize a scenario where during resorption 
formation (namely on day 8 of pregnancy), increased apoptosis in immune cells 
may boost Th2 lymphocytes expansion over Th1, in order to contrast the occurring 
inflammation and to re-establish the immunological environment existing before 
resorption. But, once resorption is formed and placental remodeling processes are 
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6.3. Are the increased TNF-α levels at the feto-maternal interface from 
mice undergoing abortion accompanied by a higher incidence of apoptosis? 
Studies suggest that de-regulation of the apoptotic process is strictly associated 
with abnormal and ectopic pregnancies, fetal growth restriction or pre-eclampsia 
(Allaire et al., 2000; Levy et al., 2002). We wondered if apoptotic activity might be 
modified in whole tissue (immune + non-immune cells) in the pathological situation 
of immunological abortion. Therefore, we analysed the activity of caspase-3 
enzyme, which mediates nuclear events during apoptosis by cleaving 
approximately 40 of 70 caspase substrates (Nicholson, 1999), and which 
represents one of the most important signs of whether cells or tissue are 
undergoing apoptosis (Cohen, 1997). Knofler and colleagues (2000) demonstrated 
that pro-inflammatory cytokines such as TNF-α may induce apoptosis in primary 
and immortalized first trimester cytotrophoblasts by increasing their caspase-3 
activity. Therefore, our hypothesis was that apoptosis would be augmented in 
these mice as TNF-alpha levels were up-regulated. Contrary to our expectations, 
the analysis of caspase-3 activity revealed a slight and non-significant up-
regulation of this enzymatic activity in placental tissues from mice undergoing 
abortion compared to the controls. Accordingly to the caspase activity data, further 
investigations about apoptotic process such as the analysis of DNA fragmentation 
- through TUNEL assay – confirmed statistically non-significant differences in the 
number of apoptotic cells at the feto-maternal interface from both experimental 
groups. Taken together, these results suggest that apoptosis might not be up-
regulated, thus also not involved in a Th1-induced murine abortion. In other words 
high Th1 levels at the fetal-maternal interface were not able to boost apoptosis in 
abortion-prone mice or if so, this is contrasted by other mechanisms. With these 
data, we then focused our attention on NF-kappa B (NFκB), a transcription factor 
playing important roles in inflammation, autoimmune response, cell proliferation 
and apoptosis by regulating the genes involved in these processes (Pahl, 1999). 
As matter of fact, NFκB is activated by various intra- and extra- cellular stimuli 
including cytokines such as TNF-α. This pro-inflammatory cytokine negatively 
regulates its own ability to induce apoptosis by concomitantly activating NF-kappa 
B (Baldwin, 1996). In the absence of TNF-alpha stimulation, NFκB is associated 
with its inhibitor I-kappa B in the cytoplasm, whereas with TNF-alpha, the inhibitor 
 - 95 - 
is degraded through ubiquitination (Pimentel-Muinos and Seed, 1999). The ability 
of NFκB to suppress apoptosis is one of the main NFκB functions determining its 
pro-inflammatory activity and implicating it in the pathogenesis of inflammatory 
diseases, oncogenesis and cancer therapy resistance (Karin and Lin, 2002). 
Therefore, NFκB could be activated directly by TNF-alpha to antagonize its own 
ability to induce apoptosis, thus protecting fetal development. Another possibility of 
no apoptosis despite high TNF-α levels is that the time point of analysis we chose 
was too late. As already indicated, we included in these study samples obtained 
on day 14 of pregnancy, a period during which placental remodeling processes 
have already taken place and the placenta is completely formed. However, we 
analysed samples on day 8 of pregnancy and found similar results. In addition, the 
interpretation of the results obtained from an earlier time point of analysis may be 
hampered by the fact that apoptosis is actively taking place for the normal 
development of tissue. Recently, Savion and colleagues (2002) analysed the role 
of apoptosis in murine pregnancy loss induced by LPS. In this context, they 
observed a marked correlation between abortion and apoptosis. Their study 
described that during resorption formation apoptosis is up-regulated, while the 
anti-apoptotic molecules are not. On the contrary, they observed down-regulation 
of apoptosis when resorption is complete, thus underlying a complex mechanism 
reflecting a specific regulation of apoptotic process tending to protect and maintain 
safety the physiology of the neighbor placentas, which have not been resorbed. 
However, it is important to say that LPS injection is a much more potent stimulus 
when compared to our model, in which the abortion events occur spontaneously. 
In the light of this consideration, we decided to analyse pro- or anti-apoptotic 
molecules in the CBA/J x DBA/2J combination using as controls BALB/c-mated 
animals as controls. 
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6.4. Pro- or anti-apoptotic molecules and regulation of apoptosis in a Th1-
induced mouse abortion model. Is Bcl-2 the main player? 
Considering that several studies revealed that the different cytokine profile at the 
feto-maternal interface influences pregnancy outcome (Lin et al. 1993; Chaouat et 
al., 1995, 2003; Clark et al., 1999; Raghupathy et al., 1997, 1999, 2001.), we 
wondered whether a naturally occurring TNF-α augmentation in the abortion-probe 
combination could interfere with the apoptotic process. Surprisingly, our study 
revealed no increased apoptosis incidence at the feto-maternal interface from 
mice undergoing abortion when compared to controls, despite high levels TNF-α, 
a well-known apoptosis-inductor. This shows that apoptosis does not play the 
main role in perpetuating abortion at least on day 14 of gestation. We then decided 
to analyze the levels of pro- and anti-apoptotic molecules to investigate whether 
there is a dysregulation at this level. 
The apoptotic process is regulated by the Bcl-2 family, a large family of related, 
conserved protein products, each associated with either the inhibition or 
augmentation of cell death (Vander Heiden et al., 1999). The caspase family 
(cysteine proteases) represents the major executioners of programmed cell death 
(Hengartner, 2000). Proteins of the Bcl-2 family regulate apoptosis in part by 
affecting the mitochondrial compartmentalization of cytochrome c. Expression of 
Bcl-2 or Bcl-xL prevents redistribution of cytochrome c, while bax promotes its 
release (Hengartner, 2000). Bcl-2 was the first proto-oncogene identified, which 
inhibits apoptosis in a variety of cells (Hockenberry et al., 1990; 1991). All the 
proteins belonging to the Bcl-2 family share structural homology in four peptide 
sequences called Bcl-2-homology (BH) domains. Specific features of the four BH 
domains determine the function of these proteins. Caspases are best known as 
executioners of apoptotic cell death and their activation is considered a “point of 
no return” commitment to cell death (Nicholson, 1999). Based on structure and 
function, caspases are divided into two groups such as initiator – activated through 
oligomerization - and effector caspases, which required cleavage by an initiator 
caspase to be activated (Thornberry and Lazebnick, 1998). Despite this role, 
studies suggested that caspases might have a function outside apoptosis. In 
addiction to the well-establish role of caspase-1 in the production of active IL-1β 
and IL-18 in inflammation (Dinarello, 1998), it has been observed that cells 
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survived despite activated caspases. As first reported by Miossec et al., during T 
lymphocyte stimulation caspase-3 is activated without inducing apoptosis, (1997). 
This opens a debate on a possible non-apoptotic function of caspases in a 
complex scenario with several other players. In the present work, we analysed 
mRNA and protein levels pro- and anti-apoptotic molecules by employing real time 
RT-PCR and WB respectively. With IHC we aimed to analyse the cellular 
localization of the proteins to identify their cellular source. We did this in samples 
obtained from abortion-prone as well as from normal pregnant mice. We analysed 
Bcl-xS, Bax, caspase-3- as the cell death inductors (pro-apoptosis) and Bcl-xL, 
Bag-1, Bcl-2, which are apoptotic repressors (anti-apoptosis). Ratts and 
colleagues (2000) showed the cellular expression of three important members of 
Bcl-2 family, Bcl-2, Bax and Bak, in human placenta. It has been observed that the 
expression of both anti- and pro- apoptotic molecules during normal tissue 
turnover, such as in placental remodeling, counterbalances the proliferation of 
trophoblast cells (Danihel et al., 2002). Other studies confirmed the important roles 
of the Bcl-2 family members in different tissues. For example, bcl-2 deletion in 
mice allows offspring to complete embryonic development, but the fetuses display 
growth retardation and the newborn die early (Veis et al., 1993). On the other 
hand, deletion of bcl-xL gene in mice causes fetal death at day 13th of pregnancy 
(Motoyama et al., 1995), whereas bax deletion gene results in normal 
development but infertility (Knudson et al., 1995).  
In all molecules we investigated, we observed that mice undergoing abortion had 
elevated levels of Bcl-2 protein in placenta when compared to normal pregnant 
mice as analysed by immunohistochemistry and Western Blot. Bcl-2 represents a 
multiple-function molecule which lays the a main role during apoptosis. In fact, Bcl-
2 expression may regulate the mitochondrial physiology by inhibiting the 
generation of reactive oxygen species and intracellular acidification (Vander-
Heiden and Thompson, 1999), or stabilizing the mitochondrial membrane potential 
and its proton flux (Hengartner, 2000). Bcl-2 is able to attenuate apoptosis induced 
by TNF-alpha (Smyth et al., 1997). In fact, TNF-alpha binding to its receptor 
activates sphingomyelin hydrolysis, generates the second messenger ceramide, 
which induces apoptosis (Smyth et al., 1997). The anti-apoptotic molecule Bcl-2 
can interfere with the ceramide signal. Danihel et al. (2002) delineated a protective 
role for Bcl-2 during human pregnancy. Using immunohistochemical studies, they 
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observed that Bcl-2 protein was exclusively localized in the cytoplasm of 
syncytiotrophoblast throughout gestation with a similar abundance in preterm as 
well as in term placentas. Taking these facts into account, it is tempting to 
speculate that this anti-apoptotic marker is indispensable to ensure the correct 
placental physiology together with development of the fetus. In our analysis, all 
molecules (pro- and anti-apoptotic) were expressed in all placental cell types 
(giant cells, spongiotrophoblast and labyrinthic cells) as well as in decidual cells in 
different patterns and intensities. Our study revealed that mice undergoing 
abortion had elevated levels of Bcl-2 protein in the placenta when compared to 
normal pregnant mice. Moreover, despite up-regulated levels of TNF-alpha, 
caspase-3 activity, thus apoptosis, is not up-regulated. Bcl-2 might protect from 
apoptosis by blocking caspase activity, which is necessary to end apoptosis. In 
accordance with this, Cory and Adams (2002) proposed a model where Bcl-2 
might control several initiator caspases, which are upstream or independently of 
any mitochondrial breach. However, the nature of the immediate effectors of Bcl-2 
function remains an open point. Interestingly, Bcl-2 mRNA was slightly up-
regulated in decidual but not in placental tissue. This may indicate the decidua as 
a preferential site for regulating cell death. Decidual tissue posseses several 
functions that are vital for pregnancy maintenance, such as immunomodulation, 
nutrition, endocrine functions and regulation of invasion. Therefore, this tissue 
represents a key point during gestation by orchestrating cross talk between 
several molecules and processes. In a recent work, Wei et al. (2005) investigated 
for the first time the expression of Bcl-2 and p53 in relation to apoptosis at the feto-
maternal interface of the rhesus monkey at very early stages of gestation, 
reporting that the localization of Bcl-2 protein follows that of apoptotic nuclei, and 
its expression level increases as the development of the placenta progresses. 
They proposed that the expression of Bcl-2 is not sufficient to completely inhibit 
apoptosis but becomes a protective mechanism tending to limit the degree of 
nuclear degradation boosting cell survival. Savion and colleagues (2002) analysed 
the role of apoptosis in murine pregnancy loss induced by LPS, focusing their 
attention on Bcl-2 and p53 expression. Interestingly, they described high apoptosis 
and lower Bcl-2 when the resorption is being formed, while this situation changes 
completely to higher Bcl-2 levels and low apoptosis when the resorption process 
was complete, probably to protect the fetuses which have survived. In agreement 
 - 99 - 
with these observations, our analysis revealed up-regulated levels of Bcl-2 on day 
14, thus 6 days after abortion took place. Previous data proposed a similar 
inhibitory effect of Bcl-2 on apoptosis, suggesting that bcl-2 might attenuate cell 
death either directly or through its dimerization with a related gene product, bax. 
Therefore, we hypothesized that Bcl-2 augmentation in our model may reflect a 
compensatory mechanism tending to protect and maintain the physiology of the 
placentas which have been not resorbed. This hypothetical scenario is 




 Hypothetical scenario 
proposed for the cross talk 
between Bcl-2 and other 
components of the feto-
maternal interface. On day 8 
of pregnancy, when 
resorption takes place, 
apoptosis may be up-
regulated, whereas Bcl-2 
expression diminished (A). 
Insufficient Bcl-2 levels could 
prevent apoptosis. After the 
resorption process is 
complete, the healthy 
placentas closed to the 
resorbed continue to grow in 
order to ensure a correct fetal 
development. At that point a 
higher expression of Bcl-2 
may help the tissue to grow, 
while leading to down-
regulation of programmed cell death. Bcl-2 up-regulation may represent a compensatory 
mechanism tending to protect the physiology of the unresorbed placentas in order to permit fetal 
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6.5. Is the pregnancy protective effect of HO-1 related to diminished 
apoptosis at the feto-maternal interface?  
Recent data on heme oxygenase-1 suggest that this enzyme might be a potential 
target of novel therapies designed to protect the fetus from maternal 
immunological rejection (Zenclussen et al., 2005; Sollwedel et al., 2005; M.L. 
Zenclussen et al., 2006). Interestingly, HO-1 down-regulation is directly related 
with graft rejection (Soares et al., 1998) or murine abortion (Zenclussen et al., 
2005; Sollwedel et al., 2005; M.L. Zenclussen et al., 2006). Moreover, a significant 
reduction of HO-2 expression was observed in placenta samples from patients 
with pregnancy complications compared to normal pregnant women (Zenclussen 
et al., 2003b). The protective effect of HO-1 on pregnancy outcome could be due 
to the avoidance of free heme accumulation or to protective effects of its 
metabolites (CO and ferritin). Up-regulation of HO-1 via gene therapy protects 
fetus from rejection and augments Th2 cytokine production locally (Zenclussen 
M.L. et al., 2006). However, up-regulation of HO-1 by Co-PP did not augment Th2 
or diminish Th1 and was nevertheless pregnancy-protective. Thus, other 
mechanisms may be involved: one possibility is that HO-1 protects the fetus from 
rejection due to its well characterized anti-apoptotic properties, Petrache et al. 
(2000) and Brouard et al. (2000) observed that anti-apoptotic effect of HO-1 may 
be mediated via carbon monoxide. Accordingly, over-expression of HO-1 in 
fibroblast or in endothelial cells (Soares et al., 1998) protects these cells from 
TNF-α mediated apoptosis. Ferris et al. (1999) proposed that the anti-apoptotic 
action of HO-1 is correlated with its ability to regulate intracellular iron. Moreover, 
HO-1 up-regulation by gene therapy was associated with diminished apoptosis at 
the feto-maternal interface and augmented Bag-1 levels (Zenclussen M.L. et al., 
2006). In the context of this work, HO-1 has been up- or down-regulated by means 
of Co-PP or Zn-PP applications, respectively, in DBA/2J-mated CBA/J female 
mice during implantation. When we analysed important hallmarks of apoptosis 
such as caspase-3 enzyme activity and the DNA fragmentation, we observed 
slightly diminished apoptotic activity in those mice previously treated with Co-PP 
as compared to PBS-treated abortion-prone mice. These results suggest an anti-
apoptotic effect of HO-1 at the feto-maternal interface. After observing an anti 
apoptotic effect of HO-1, we further analysed and quantified anti- and pro-
apoptotic-related molecules at the protein and mRNA levels. No changes could be 
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observed for caspase-3, Bcl-xS, Bcl-xL and Bcl-2. However, when analyzing the 
anti-apoptotic molecule Bag-1, both mRNA and protein analyses revealed its up-
regulation in samples from animals previously treated with Co-PP as compared to 
the controls. These data confirm the data obtained on diminished apoptosis and 
strongly suggest a tissue protective effect of HO-1 up-regulation during 
implantation. Moreover, Zn-PP application, which diminished HO-1 and HO-2, also 
diminished Bag-1 mRNA and protein, confirming our hypothesis on HO-1 up-
regulating Bag-1. Considering these facts, we postulate herein that HO-1 could 
protect the fetus from abortion by up-regulating the cytoprotective molecule Bag-1. 
Bag-1 belongs to the Bcl-2 family and its ability to suppress apoptosis has been 
demonstrated in various cells (Townsend et al., 2003). The mechanisms involved 
are not fully characterized yet. A possible target of action could be Bcl-2 protein, a 
Bag-1 interacting partner (Hengartner, 2000). Interestingly, Townsend et al. (2003) 
have shown that Bag-1 protects cardiac myocytes from apoptosis through 
association with heat shock proteins such as HSC70/HSP70, thus forming a 
specific complex with them. In the light of our results, we can speculate that Bag-1 
mediates fetal tissue protection, being the mechanisms involved in its 
cytoprotective effect still under investigation. 
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7. Summary 
 
Several burning questions remain unanswered in pregnancy-related research. 
Pro- and anti- inflammatory cytokines orchestrate an intriguing interaction leading 
either to the development of a normal individual or to its rejection.  
Augmented Th1 cytokine production is involved in immunological rejection of the 
fetus. Of these Th1 cytokines, particularly TNF-α is know to trigger apoptosis. The 
present work was aimed to investigate the incidence of apoptosis in a well-known 
experimental model of Th1-induced abortion, characterized by increased local 
TNF-α levels. Despite elevated Th1 levels at the feto-maternal interface, mice 
undergoing abortion presented apoptotic rates comparable to normal pregnant 
animals. Interestingly, we found a significant up-regulation of the anti-apoptotic 
Bcl-2 protein at the feto-maternal interface of abortion-prone mice, while no 
changes could be observed for pro-apoptotic molecules. We observed no 
evidence of increased apoptosis in mice undergoing immunological abortion in 
spite of elevated TNF-alpha levels. This is probably due to a selective up-
regulation of anti-apoptotic pathways (i.e. Bcl-2) at the feto-maternal interface as 
compensatory and/or protective mechanisms.  
Therefore, in this study we proposed that Bcl-2 could represent an important 
modulator to contrast apoptosis after resorption formation in order to keep the 
physiology of surviving placentas safe to enable them develop normally to nourish 
the fetuses to be born. 
It has been proposed that HO-1has a protective role during allogeneic pregnancy. 
Our data show that the up-regulation of HO-1 by Co-PP injection prevents 
abortion, while it is able to enhance Bag-1 levels, a well-known suppressor of 
apoptosis. These data strongly suggest that apoptosis, despite having a 
secondary role in the normal situation is involved in pregnancy success as its 
blockage is associated with fetal protection. Moreover, it is tempting to define HO-
1 as a novel target for successful pregnancy-related therapies, considering that its 
mechanism of action could involve anti-apoptotic molecules such as Bag-1 in 
order to ensure correct fetal development. 
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